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1. Introduction 
Intermediate filaments (IFs) are important structural components found in most vertebrate cells. 
They are expressed in nucleus as well as in cytoplasm providing physical resilience for cells to 
withstand the mechanical stresses of the tissue in which they are expressed. Intermediate 
filaments are essential for normal tissue structure and function and are encoded in the human 
genome by 70 different genes in six subfamilies. 
 
1.1 Keratins  
 
Keratins are the structural intermediate filament proteins and account for most of the majority 
intermediate filament proteins. They form a dynamic network of 10-12 nm filaments (40–70 
kDa) which are prominent structural constituents of the cytoplasm in epithelial cells. Keratins are 
encoded by a large multigene family of more than 50 individual members and on the basis of 
gene structure and homology (Hesse et al., 2001; Moll et al., 1982; Schweizer et al., 2006), are 
classified into two major sequence types, type I (acidic) and type II (basic to neutral). The genes 
encoding type I and type II keratins are clustered on chromosomal regions 17q12–q21 and 
12q11–q13, respectively. Keratin filaments represent obligatory heterodimers of basic and acidic 
partners. The 28 type I include K9–K23 (epithelial), and the hair keratins K31–K40 and 26 type 
II include K1–K8, and the hair keratins, K81–K86 which are specifically expressed in and 
closely restricted to the various compartments of the hair follicle inner root sheath.  
Pairs of type I and type II keratins are expressed in highly specific patterns related to the 
epithelial type and stage of cellular differentiation (Kirfel et al., 2003) (figure1.1). Each keratin 
pair is characteristic of a particular epithelial differentiation programme, some epithelial cells 
express more than one pair. The coexpressed pairs of type I / type II keratins can be divided into 
three expression groups: simple keratins of one-layered epithelia (K8/K18, K20), barrier 
(keratinocytes) keratins of stratified epithelia (K5/K14, K1/K10, K3/K12, K4/K13, K6a/K16, 
K6b/K17, K19) and structural keratins which make up hard appendages like hair, nails, horns 
and reptilian scales.  
The present study is focused on keratin pair K5, K14 and their expression profile is introduced 
briefly in the following section.
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1.1.1 Keratin 5 and Keratin 14  
 
K5 (62 kDa) and K14 (51 kDa) occur as heterodimers with varying levels of expression in basal 
keratinocytes of stratified epithelia. They are strongly expressed in the basal cell layer containing 
stem cells (Fuchs and Green, 1980), uniformly expressed in stratified follicular outer root sheath, 
basal and myoepithelial cells of complex glandular epithelial tissue  (Purkis et al., 1990). The 
distinctive expression of specific keratin pairs depends largely on the tissue-type, differentiation 
status, and the physiological state. For example, as the dividing basal keratinocytes of the skin 
epidermis exit the cell cycle and embark on a program of differentiation, expression of K5 and 
K14 is downregulated and a new set of keratins, K1 and K10 are expressed in the suprabasal 
spinous layer (Byrne et al., 1994) or become activated producing K6 and K16. IL-1 is the 
primary signal initiating keratinocyte activation and expression of K6 and K16 (Freedberg et al., 
2001). The restricted expression of K14 in the basal layer of the skin epidermis is primarily 
controlled at the level of transcription and regulation of this process has been extensively studied 
using various complementary approaches. DNAse I hypersensitive site (Hs) mapping of the 
human K14 gene has identified several Hs in the 5' region that are present selectively in 
keratinocytes (Sinha et al., 2000; Sinha and Fuchs, 2001). 
 
Figure 1.1: Keratin expression in the epidermis. Basal epidermal cells express K5, K14 and K15. As basal cells 
commit to terminal differentiation, they switch off the expression of K5, K14 and K15 and induce the expression of 
K1 and K10. As epidermal cells move up through the spinous layers, they express K2e, which can pair with K10. 
Some keratins are expressed in the epidermis under special circumstances, during wound healing, keratinocytes 
express K6, K16 and K17. K9 is unique to the suprabasal layers of the palms and soles. 
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1.1.2 Keratin organization and expression in the cells 
 
Filaments of keratins are organized into a complex supra-molecular network which is extended 
over the cytoplasm and are attached to the cytoplasmic plaques of the typical epithelial cell–cell 
junctions, the desmosomes - the peripheral most portion of the cell (figure1.2). The desmosome–
intermediate filament complex (DIFC) network or scaffolding maintains the integrity of cells  
(Garrod and Chidgey, 2008). 
 
Figure 1.2:  Keratin IFs (green) are organized in a network that spans the whole cytoplasm, and are attached to desmosomes 
(red) at points of cell–cell contacts. N: nucleus. Scale bar, 10 μm (Image: Dr. S. Loeffek. IBMB, Bonn) 
 
In epithelial cells, keratin filaments are attached by adapter proteins to desmosomes (cell-cell 
adhesion) and hemidesmosomes (cell-matrix adhesion) by a filigree of proteins that make up the 
desmosomal plaques, like desmoplakin, desmogleins, desmocollins and the armadillo proteins 
plakoglobin and plakophilin (figure1.3). 
Keratins interact with desmoplakins, which are prototypes of the plakin family of cytoskeletal 
adaptor proteins and are essential for normal desmosomal adhesion. The globular head or plakin 
domain of desmoplakin is an important region for protein–protein interactions. The C-terminal 
tail domain consists of three plakin repeat domains (PRDs) and two of them represent an 
intermediate filament binding site (Choi et al., 2002). The interaction between desmoplakin with 
keratin filaments is regulated by glycine–serine–arginine rich domain located at the extreme C-
terminus (Stappenbeck et al., 1994). Mutations in the K5 tail domain cause migratory circinate 
erythema, possibly by affecting the interaction between desmosomes and keratins (Betz et al., 
2006; Gu et al., 2003; Magin et al., 2004). 
Plakoglobin is found in all cell–cell adhesive junctions and forms a bridge between adhesion 
proteins and cytoskeletal linkers (Kowalczyk et al., 1997; Mathur et al., 1994).  The C-terminal 
end of plakoglobin contains a three-Tyr cluster in its C-terminal domain (Tyr693, Tyr724, and 
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Tyr729) which is binds to the N-terminal domain of desmoplakin. Loss of plakoglobin leads to 
decreased number and altered structure of desmosomes in the epidermis of mouse skin 
 
Figure 1.3: Organization of keratin filaments in cell 
In the cytoplasm, keratin filaments are linked to plasma membrane via two linker proteins desmoplakin (DP) and 
periplakin (PP). In desmosome, desmogleins (Dsg) bind directly to plakoglobin (PG) and plakophilin (PP), which 
provide links to the N terminus (N) of desmoplakin (DP)13. DP also binds directly to the juxtamembrane domain of 
desmocollin-1a  (Dsc) and DP C- terminal domain (C) interacts with intermediate filaments (IF).  
 
(Bierkamp et al., 1996), and plakoglobin null keratinocytes exhibit weakened intercellular 
adhesion (Caldelari et al., 2001; Yin et al., 2005). Likewise, the proper recruitment and 
distribution of the PG-associated protein DP to desmosomal plaques is required for IF 
attachment as well as strong intercellular adhesion and epithelial integrity in vitro and in vivo 
(Huen et al., 2002; Vasioukhin et al., 2001). 
Epidermal keratinization is a tightly regulated process that enables epidermal cells to withstand 
mechanical stress and leads to the formation of cornified cell envelope. Epidermis is the 
protective layer that acts as a barrier against the environment and water loss. During this process, 
the keratins expressed are highly specific for the state of differentiation. For example, in the 
basal layer, as the cells move out of the proliferative compartment, K5 and K14 pair is down-
regulated, while the differentiation-specific keratins, K1 and K10 are expressed (Ishida-
Yamamoto et al., 1998). These suprabasal keratins account for nearly 85% of the total protein 
(Fuchs, 1996) of fully differentiated squamous that are sloughed off from the skin surface. 
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Interestingly, there are also a number of keratins with a restricted tissue distribution. For 
example, K9 is expressed in the suprabasal cells of palmoplantar skin and K2e is found in 
keratinocytes of the upper spinous and granular layers of the epidermis (Corden and McLean, 
1996). Non-cornifying cells of the stratified mucosa express K4 and K13 and suprabasal cells of 
the corneal epithelia express K3 and K12. In the normal epidermis, the expression of K6 and 
K16 is restricted to the outer root sheath of the hair follicle, nail bed, palmoplantar skin and the 
suprabasal layer of the orogenital mucosa. On the other hand, K17 is expressed in the nail bed, 
hair follicle, sebaceous glands, and other epidermal appendages (Langbein and Schweizer, 
2005). 
 
1.1.3 Structure and organization of keratins 
 
Keratins share common protein structural characteristics (fig. 1.2), comprising an α-helical ‘rod’ 
domain of ~ 310 amino acids (with a 50-90% sequence identity among cytokeratins of the same 
family and around 30% between cytokeratins of different families) constituted with four 
consecutive domains of highly conserved length (segment 1A accounting for 35, segment 1B for 
101, segment 2A for 19 and segment 2B for 121 amino acids). The non-α-helical parts between 
these segments, also called ‘linkers’ (L1, L12, L2), are variable in length (8–22 amino acids). 
The α-helical segments exhibit a heptad substructure in which the first and fourth positions are 
commonly occupied by apolar amino acids such as Leu, Ile, Met or Val. These hydrophobic 
amino acids generate a surface that is wound around the axis of a single right-handed α-helix in a 
left-handed manner, ultimately leading to superhelix, i.e. coiled-coil formation of two such 
molecules. 
The phasing of the heptads is interrupted by deletion or insertion of amino acids in the middle of 
segment 2B giving rise to a ‘stutter’ (Steinert et al., 1994) and is conserved in IF proteins. 
The stutter represents a helical segment which is not engaged in coiled-coil formation. Moreover, 
atomic structure analysis showed that the end of segment 2B, representing the evolutionarily 
conserved IF consensus motif (TYRKLLEGEE), is not entirely part of the coiled-coil structure, 
but bends away from the coiled-coil axis (Herrmann et al., 2000; Strelkov et al., 2002). The end-
domain sequences of type I and II cytokeratin chains contain in both sides of the rod domain the 
subdomains V1 and V2, which have variable size and sequence. The subdomains V1 and V2 
contain residues enriched by glycine/serine, the former providing the cytokeratin chain a strong 
insoluble character and facilitating the interaction with other molecules. These terminal domains 
are also important in defining the function of cytokeratin chain characteristic of a particular 
epithelial cell type. 
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Figure 1.4 (A) The tripartite domain structure of all keratin proteins, with an a-helical central rod domain dominated 
by subsegments (1A, 1B, 2A and 2B) and separated by short linker regions (L1, L12 and L2). The stutter represents 
a helical segment not engaged in coiledcoil formation. Non-helical head and tail domains at the N and C termini 
flank the rod domain, respectively. At the beginning and end of the rod domain are the highly conserved helix 
boundary sequence motives, also known as the helix initiation peptide (HIP) in the 1A domain and the helix 
termination peptide (HTP) at the end of helix 2B 
(B) Type I and type II keratin proteins readily form highly stable coiled-coil dimers (10 nm in length), in which the 
two participating monomers exhibit a parallel, in-register alignment. Dimers then associate along their lateral 
surfaces, with an antiparallel orientation, to form apolar oligomers. 
 
Like all intermediate filaments, keratin proteins form filamentous polymers in a series of 
assembly steps beginning with dimerization; dimers assemble into tetramers and octamers and 
eventually, the current hypothesis holds, into unit-length-filaments (ULF) capable of annealing 
end-to-end into long filaments. The process of formation of keratin filament  assembly initiates 
by formation of heterodimers in which compatible type I and type II polypeptide chains align in 
parallel and in exact axial register (Parry et al., 1985). Two heterodimers associate, forming 
tetramer units aligned in an antiparallel manner (Geisler et al., 1985) or which may be identical, 
as in the case of desmin IFs (Sergei et al,). Dimers and/or tetramers polymerize laterally and 
longitudinally to give rise to higher order structures comprising of equimolar amounts of a type I 
protein and a type II protein (Steinert, 1990), but no dominant intermediate has been identified or 
isolated after the tetramer stage.  
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1.1.4 Known keratin interactions and functions 
 
The variation in expression levels of keratin proteins in different cells (in surface epithelial cells 
accounting to 30% and about 1% in hepatocytes of their total proteins), and their highly specific 
patterned expression profile related to the epithelial type and stage of cellular differentiation, 
might hint towards the diverse role of keratins in cellular machinery.  
The characteristic spanning of keratin cytoskeletal network (not so in all cell types, eg. 
hepatocytes) across cytoplasm weaving the nucleus, and their attachment to cell-cell junctions – 
desmosomes, itself suggests a major functional role for keratins in regulation and maintenance of 
integrity and mechanical stability of cells and tissues. Pathogenic mutations have been 
discovered in different keratin genes (figure 1.5) causing wide range of epithelial fragility 
disorders affecting skin, mucous membranes, hair, nails, and sebaceous glands (Corden and 
McLean, 1996; Lane and McLean, 2004; Smith, 2003). The general pathology in these disease 
conditions corresponds to the expression pattern of the defective keratin protein resulting in 
structural (eg. EBS - Dowling-Meara) or pigmentation (eg. Dowling–Degos disease) disorders. A 
brief insight to this is mentioned in the next chapter.  
In multilayered epithelia, keratin filaments act as a mechanical scaffold enabling their constituent 
cells to withstand deformation without breaking (Takahashi et al., 1999; Wilson et al., 1992) 
This function is crucial in surface epithelia, such as epidermis, oral mucosa, and hair (Wong et 
al., 2000), and has been demonstrated as well for internal simple epithelia, including liver, 
trophectoderm and placenta (Hesse et al., 2000; Ku et al., 2001; Magin et al., 1998; Tamai et al., 
2000). The reported binding studies between type II keratins and the desmosomal protein 
desmoplakin (Smith and Fuchs, 1998), perinuclear collapse of keratin IFs around the nucleus in 
live cells as frequently seen in skin blistering diseases, significantly softens the cytoplasm (Beil 
et al., 2003), confirms that keratins are organized into a network architecture, which in turn is 
important for cellular micromechanics (Beil et al., 2003) 
 
Keratins and vesicle transport 
 
The keratinocyte pigmentation disorder Dowling–Degos disease (DDD) (Dowling and 
Freudenthal, 1938) due to K5 haploinsufficiency, rare skin disorders like EBS with mottled 
pigmentation (Uttam et al., 1996), and Naegeli–Franceschetti–Jadassohn syndrome are caused by 
mutations residing in the head domains of K5 and K14 (Betz et al., 2006; Harel et al., 2006; Liao 
et al., 2007; Lugassy et al., 2006; Uttam et al., 1996). In contrast to most other keratinopathies, 
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the described haploinsufficiency in K5 (DDD) which results from premature stop codons in the 
K5 gene, affects melanosome distribution in keratinocytes but not the integrity of the keratin 
cytoskeleton (Betz et al., 2006; Liao et al., 2007) and is the same in latter mentioned conditions 
which show an intact keratin organization with disorganized distribution of melanosomes in 
keratinocytes.  
 
 
Figure 1.5 : Schematic representation of keratin protein depicting the structural domains and common mutation sites 
in epidermolysis bullosa simplex.  
Common sites of dominant mutations and their corresponding EBS phenotypes are depicted above the diagram; the 
locations of recessive mutations are shown below. The relative height of the bars reflects the relative frequency of 
the mutations.  
 
Pigmentation of skin depends on melanin synthesis and transport of melanosomes- a lysosome 
related organelles which form supranuclear caps in keratinocytes. Biogenesis and transport of 
melanosomes in melanocytes depend on the regulation of actin and myosin motors by the 
GTPase Rab27a and Rab effectors (Marks and Seabra, 2001). The mechanism of uptake of 
melanosomes into basal keratinocytes and its distribution, how do the mutations in keratins 
responsible for pigmentation disorders disturb the physiological cellular process still remains an 
open question, the reason being, lack of information about the keratin associated proteins which 
might get affected due to mutations in keratin genes inturn influencing the cellular machinery.    
Further support for a role of keratins in melanosome transport comes from the analysis of mice 
with chemically induced mutations in K1, K2e and K4 (Fitch et al., 2003; McGowan et al., 2006; 
McGowan et al., 2007). The interaction results of the K5 head domain with dynein light and 
intermediate chains (Betz et al., 2006), report of dynein involvement in the centripetal transport 
of melanosomes in keratinocytes where they form supranuclear caps (Byers et al., 2003) hints at 
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the role of keratins in their transport and distribution which holds great promise for the 
understanding of a general role of IF proteins in vesicle trasnsport. 
 
Role of keratins in wound healing 
 
Re-epithelialization is a pivotal event in wound healing process. It involves the migration and 
cornification of perilesional basal keratinocytes across wound bed for restoration of an intact 
epidermal barrier through wound. In the initial process of wound healing the basal keratinocytes 
express K6 and K16 (Wong and Coulombe, 2003), unlike the normal skin which expresses K5 
and K14 pair. More experimental studies have shown that after skin wounding, K6 and K16 are 
rapidly induced within 6h in human keratinocytes at the wound edge, before migration and 
regeneration begins (Paladini et al., 1996). In epidermal wounding situation, transcription of the 
Krt6/16/17 genes is induced and Krt1/10 gene expression is reduced (Zhong et al., 2004), 
presumably providing the cell with a more pliable cytoskeleton that favours keratinocyte 
migration for wound closure. K6a knockout mice showed delayed re-epithelialization upon 
partial thickness skin wounding (Wojcik et al., 2000) and loss of K17 compromised wound 
healing in mouse embryos (Mazzalupo et al., 2003).  
 
Role of keratins in microtubule localization  
 
It has been shown that intermediate filaments mediate cross-talk among other components of the 
cytoskeleton (Chang and Goldman, 2004). Centrosomes are known to be located under the apical 
domain in simple epithelial cells, instead of a perinuclear localization as in other cell types 
(Apodaca et al., 1994; Meads and Schroer, 1995; Salas, 1999). Several research groups have 
shown that γ-tubulin–containing structures are attached to intermediate filaments (IFs) (Figueroa 
et al., 2002) and that this attachment is responsible for the apical distribution of centrosomes in 
simple epithelial cells (Mulari et al., 2003; Salas, 1999). Similarly, overexpressed keratin 
accumulates around the centrosome (Blouin et al., 1990), this colocalization can be disrupted by 
Cdk1/cyclinB mediated phosphorylation in interphasic cells, and is naturally lost in mitotic cells. 
Keratin knock-downs in tissue culture cells where the apical localization of centrosomes and 
non-centrosomal γ–TurCs is abrogated (Salas, 1999) and the phenotype of the K8-null mice 
villus enterocytes (Ameen et al., 2001) coincided to show loss of the apical γ–tubulin layer and 
disorganization (not depolymerization) of MTs with loss of the apico-basal arrangement. Yet, a 
full mechanistic explanation for these phenotypes has to be established. An interesting possibility 
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of interactions between keratin filaments and molecular motors (Betz et al., 2006) (kinesins and 
cytoplasmic dyneins) which may participate in the organization of the microtubular architecture 
similar to that of vimentin (Helfand et al., 2004) still remains and has not been demonstrated so 
far.  
 
Role of keratins in epithelial polarization 
 
K8-null mice show decreased expression of apical proteins in the apical membrane. In some 
cases, mispolarization or intracellular localization was observed, suggesting that membrane 
traffic was the cause, rather than transcriptional/translational defects. In general, the effects were 
observed in epithelia where K7, a type II keratin redundant to K8, was not expressed. 
It might also be due to the changes in MT architecture and even, that IFs may serve as scaffolds 
for extrinsic membrane proteins that, in turn interact with membrane proteins.  
An example of this possibility is the phenotype of transgenic mice overexpressing K8 which 
showed an extensive atrophy of the intestinal brush border. An analysis of the subcellular 
localization of ezrin showed it bound to the abnormal cytoplasmic IFs while lacking under the 
apical membrane (Wald et al., 2005). Ezrin is known to connect actin to the PDZ protein EBP50, 
and to membrane proteins (Bretscher et al., 2002), interactions that aid in the retention of apical 
membrane proteins such as CFTR (Guggino and Stanton, 2006). More data will be necessary to 
determine the relevance of these and other possible mechanisms in the function of IFs. 
 
Keratin response in stress conditions 
 
The studies in mice that overexpress Arg89→Cys K18 as well as in K8-null mice demonstrated 
the importance of an intact IF network in imparting protection to hepatocytes from several 
stresses (Ku et al., 1999; Zatloukal et al., 2000). Pancreatic acinar cells were far more resilient 
than their hepatocyte counterparts upon exposure to two established pancreatic injury models 
(Toivola et al., 2000) suggesting that the same keratins may function differently in the pancreas 
and liver, or that other stress-related compensatory mechanisms are found in the pancreas. Along 
with the strong association of simple epithelial keratins with cytoprotection upon exposure to 
nonmechanical stresses (Ku et al., 1999), the induced expression of keratins upon injury to the 
liver (Cadrin et al., 2000; Denk et al., 2000) and pancreas suggests that keratins may function as 
stress proteins similar like heat shock protein (Hsp) family. Recent studies using transgenic mice 
over expressing K8 G61C mutant (inhibits phosphorylation of K8 at S73 by stress-activated 
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protein kinases such as p38, JNK and p42) has shown an increased susceptibility to stress-
induced liver injury and apoptosis (Ku and Omary, 2006). Consequently, a similar susceptibility 
to stress was also observed in the S73A mutant wherein the site for phosphorylation is destroyed.  
Such a role can be envisaged to occur either directly and be affected by scaffolding, chaperone or 
‘sponge’-type activities absorbing the stress-activated phosphate kinases, thereby reducing their 
untoward effects and hence protect the cells from injury, or indirectly via the known association 
of keratins with Hsp family members. During oxidative stress or exposure to other toxins 
disrupts the keratin-Raf-1 association (Ku et al., 2004) in a phosphorylation-dependent manner, 
suggesting keratins regulate Raf-1 kinase signaling potential by kinase sequestration, activation, 
inactivation or compartmentalization. 
The results of the spatiotemporal and differential regulation of keratin phosphorylation like 
Phosphorylation of K20 S13 in mucus-secreting goblet cells, but not in the other K20-expressing 
enterocytes (Tao et al., 2006), and hyperphosphorylation of K20 during starvation-induced 
mucin secretion indicates the complex functional properties of specific epithelial cell types. 
Loss of maternal TNFα increased the survival of keratin deficient embryos (Caulin et al., 2000; 
Jaquemar et al., 2003) and keratins have been shown to moderate apoptosis in Fas mediated 
apoptosis (Ku et al., 2003) pathway either induced by death receptor or cell-intrinsic pathways. 
 
1.1.5 Keratin disorders in humans 
 
Mutations in 19 different keratin genes have so far been identified as the cause of at least 15 
different genetic diseases (table 1.1). Most disorders are transmitted in an autosomal dominant 
mode, although there are some reports of recessive transmission (Corden and McLean, 1996; 
Irvine and McLean, 1999; Lane and McLean, 2004; Porter and Lane, 2003; Smith, 2003). The 
phenotypes of keratin disorders usually reflect the expression pattern of the mutated keratins 
ranging from very severe to relatively mild blistering because of fragile basal layer of epidermal 
keratinocytes to pigmentation disorders. In general, a mutation in either one of a particular 
keratin pair leads to the same disorder. However, there are instances in which distinctly different 
phenotypes result from mutations in the same keratin (table 1.1).  
Most pathogenic keratin mutations are dominant mutations caused by missense mutations that 
alter amino acids at the start of ‘1A’ rod domain and the end of the ‘2B’ rod domain (fig1.2 A) 
which are called as helix initiation and termination motifs respectively. These helix boundary 
peptides represent genetic “hot spots” for mutations in almost all hereditary keratin disorders. 
The most commonly affected amino acid is an arginine residue near the start of helix 1A that is 
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conserved in all type I keratins (Rugg and Leigh, 2004). Mutations occurring outside the helix 
boundary regions are frequently associated with milder or unusual phenotypes. Mutations that 
affect residues in the head and tail domains often result in conditions that are distinct from those 
caused by mutations in the central region of the keratin molecule suggesting that these regions of 
the keratin molecules may have different functions to the rod domain. 
The precise phenotype of each disease apparently reflects the spatial level of expression of the 
mutated genes, as well as the types and positions of the mutations and their consequences at 
mRNA and protein levels. 
 
Disorders of K5 and K14 
 
The first keratin disorder to be identified was epidermolysis bullosa simplex (EBS). EBS is 
caused by mutations in the genes for keratins 5 (KRT5)/14 (KRT14), describes a heterogeneous 
group of heritable skin-blistering disorders in which is characterized by rupture of the basal 
keratinocytes of the epidermis in response to mild physical trauma. Based on severity, 
distribution, and seasonal variations in blistering, EBS is categorized in three groups.  
I. EBS Dowling-Meara (EBS-DM): is the most severe subtype characterized by widespread, 
herpetiform blistering and intracellular keratin aggregates. Pathogenic defects are due to 
missense mutations clustering at the highly conserved boundaries of the alpha-helical rod of K5 
or K14. In most of the identified mutations, a particular arginine codon within the helix initiation 
peptide in K14 (R125) is found to be replaced either by cysteine/histidine and in K5 substitution 
of a highly conserved amino acid isoleucine to threonine (I466T) within this critical region. 
 II.   EBS Kobner (EBS-K):  is characterized by milder, generalized blistering of the skin without 
apparent clustering, often in response to minor trauma and induced by increased ambient 
temperature. Hands, feet and extremities are most consistently affected. Pathogenic condition 
arises due to T-to-C transition within exon 7 of the KRT5 gene at the nucleotide level which 
results in substitution of a leucine by a proline at the amino acid level. In KRT14 a heterozygous 
mutations at 2B helix domain G1231T creates a premature stop codon and G1237A mutation that 
produces a conservative amino acid change (alanine to threonine) at position 413 (A413T) have 
been identified as the cause of EBS-K.  
III. EBS Weber-Cockayne (EBS-WC): is the most common, relatively mild, localized subtype of 
EBS, characterized by blisters or pigmentation disorders that are confined to the hands, feet and 
areas of friction or trauma. In this relatively form of EBS, pathogenic mutations lie in most cases 
outside of the helix boundaries, elsewhere in the rod domain of K5 (T-->G point mutation in the 
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second base position of codon 161) or K14 (in-frame deletion), including the non-helical L12 
linker motif or in the amino terminal homologous domain of K5 resulting in amino acid 
substitutions.  
Table 1.1 gives an overview of other types of disorders caused due to the discrepancies in 
kerartins. The detrimental effects caused by mutations in keratins have various underlying 
molecular mechanism which still remain elusive. Identification of keratin associated proteins 
involved in various cellular processes will be a major advantage to this end.  
Different available techniques which can be used to identify keratin associated proteins are 
briefly introduced in the next chapter. 
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Type II Type I Expression pattern Human disease 
Bullous congenital ichthyosiform 
erythroderma or epidermolytic 
hyperkeratosis 
Autosomal recessive epidermolytic 
hyperkeratosis 
Diffuse non-epidermolytic palmoplantar 
keratoderma* 
Ichthyosis hystrix Curth-Macklin* 
K1* K10* 
suprabasal cells of cornified  
squamous epithelia 
Palmoplantar keratoderma with 
tonotubules* 
K3 K12 Corneal epithelium Meesmann corneal epithelial dystrophy 
K4 K13 suprabasal cells of non-cornified squamous epithelia White sponge nevus 
Epidermolysis bullosa simplex types   
Weber-Cockayne, Koebner,  Dowling-
Meara 
Autosomal-recessive Epidermolysis   
bullosa simplex 
EBS with mottled pigmentation* 
K5* K14* basal cells of stratified epithelia 
Dowling-Degos disease* 
Pachyonychia congenita type I 
K6a K16* 
suprabasal orogenital mucosa; 
palmoplantar epidermis; epidermal 
appendages, epidermal expression 
induced by trauma/wound healing Focal non-epidermolytic PPK* 
Pachyonychia congenita type II 
K6b K17* like K6a/K16 
Steatocystoma multiplex* 
K2 (K2e)  Upper spinous and granular layer of cornified squamous epithelia Ichthyosis bullosa of Siemens 
K9  Suprabasal layers of palmoplantar epidermis Epidermolytic palmoplantar keratoderma 
K8 K18 Simple epithelia 
Various liver diseases, inflammatory 
 bowel disease 
K31 (Ha1) K81 (Hb1)* Hair shaft Monilethrix* 
K33 (Ha3) K83 (Hb3)*   
K36 (Ha6) K86 (Hb6)*   
Table 1.1: Expression patterns of keratins and the associated human disorders. The former designation is given 
in brackets. *   indicates diseases for which mutations have been found in only one of a keratin pair 
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1.2 Protein-protein interactions  
Proteins control and mediate many of the biological activities of cells. Although some proteins 
act as single monomeric units (enzymes that catalyze changes in small-molecule substrates), a 
significant percentage, if not, the majority of all proteins function in association with partner 
molecules or as components of large molecular assemblies. Their intrinsic biochemical and/or 
catalytic activities are, to large extent, regulated/modulated by dynamic, spatially and temporally 
confined physical (direct) and functional (indirect) protein–protein interactions. Protein–protein 
interactions (PPIs) are an essential aspect in virtually all biological processes, including the 
formation of macromolecular structures, cell signaling (Choi et al., 1994), regulation (Kischkel et 
al., 1995), and metabolic pathways. In addition, PPIs have emerged as important drug targets 
with small molecules binding to ‘hotspots’ on the protein contact surfaces (Ryan and Matthews, 
2005; Wells and McClendon, 2007). Aberrant protein-protein interactions have the potential to 
cause or contribute to human disease. The modulation of these interactions by drug-like 
molecules would offer previously unavailable opportunities to explore the relevance and 
therapeutic significance of pre-selected protein-protein interactions.  
The availability of completed genome sequences of several eukaryotic and prokaryotic species 
has shifted the focus towards the identification and characterization of all gene products that are 
expressed in a given organism. In order to cope with the huge amounts of data that have been 
generated by large-scale sequencing projects, high-throughout methodologies (Auerbach et al., 
2002) has to be applied in the process of identifying the interacting partners and their functional 
significance. 
1.2.1 General classification of detection methods 
The study of protein-protein interactions can be conceptually divided into three major domains: 
identification, characterization and manipulation. At present different methods have been 
developed to study and analyse protein-protein interactions, they can be   broadly categorized as : 
I. Genetic approaches  
1.Two Hybrid Systems  
 a) Yeast two hybrid system (Y2H) 
b) Bacterial two-hybrid system (B2H) 
c) Mammalian two-hybrid system (M2H) 
d) Phage display system  
e) Protein fragment complementation assays (PCA)  
 - 15 -
  Introduction                
2. Three-hybrid systems 
 a) Kinase three-hybrid system (tri-brid) 
 b) Protein three-hybrid system 
 c) Peptide ligand and small ligand three-hybrid system 
 d) RNA three-hybrid system 
II. Biochemical methods 
a) Pull down studies using tagged fusion proteins 
b) Coimmunoprecipitation 
c) Far western blot technique 
d) Protein microarrays 
e) Matrix assisted laser desorption/ionization-time of flight(MALDI-TOF) 
III. Physical methods  
a) Protein Affinity Chromatography 
b) Affinity Blotting 
c) Tandem Affinity Purification (TAP) 
IV. Biophysical methods 
a) Fluorescence resonance energy transfer (FRET) 
b) Bioluminescence resonance energy transfer (BRET) 
c) Bimolecular fluorescence complementation (BiFC) 
d) Atomic force microscopy (AFM) 
Living cells monitor parameters of interest in their environment for any given interaction 
between the proteins. Each of the above mentioned techniques have been widely used to identify 
& characterize the interaction partners. As each technique has unique advantages & limitations, 
appropriate method has to be selected to create nearest internal representations of physiological 
conditions to implement appropriate adaptive responses to changing conditions depending on the 
scope and goal of the study to be conducted. 
In this present study two of the systems has been successfully used and are briefly introduced in 
the next section.  
 
1.2.2 Yeast two-hybrid 
 
The yeast two-hybrid system is an in vivo assay that detects binary physical interactions. The 
interaction between a ‘bait’ fusion and a ‘prey’ fusion re-constitutes a functional secondary 
signal which is used as read-out of the assay (growth at restrictive temperature, formation of 
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functional transcription factor). Many improvised methods have been established since its first 
application in 1989 (Fields and Song, 1989). The system is economical, scalable and hence 
perfectly suited for automated high-throughput approaches (Drewes and Bouwmeester, 2003). 
 
Sos recruitment system (SRS) 
 
This system is based upon generating fusion proteins whose interaction in the yeast cytoplasm 
activates the Ras-signaling pathway, inducing cell growth. This system enables the study of 
protein interactions that cannot be assayed by conventional two-hybrid or interaction trap 
systems. These include proteins that are transcriptional activators or repressors, proteins that 
require post-translational modification in the cytoplasm, and proteins that are toxic to yeast in 
conventional two-hybrid systems. 
 
 
Figure 1.6:  Schematic representation of SRS 
 
In this system yeast S. cerevisiae temperature-sensitive mutant strain cdc25H, containing a point 
mutation in CDC25 gene which is the yeast homolog of human Sos(hSos) gene, coding for 
guanyl nucleotide exchange factor that binds and activates Ras (Aronheim et al., 1994), 
beginning the Ras signal transduction pathway. The CDC25 mutated gene is complemented with 
hSos fused with the bait protein and the target protein/expression library is expressed as a fusion 
protein with a myristylation sequence that anchors the hSos to the plasma membrane. These 
fusion proteins are coexpressed in the cdc25H yeast strain, and the yeast cells are incubated at 
the restrictive temperature of 37°C. Physical interaction between bait and target proteins recruit 
hSos protein to membrane, thereby activating the Ras-signaling pathway and allowing the 
cdc25H yeast strain to grow at restrictive temperature 37°C. 
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1.2.3 The Bimolecular Fluorescence Complementation assay 
 
Direct visualization of protein complexes in living cells enables investigation of interactions in 
their normal environment. Many proteins can be divided into fragments that can associate to 
produce a functional complex. Direct visualization of protein complexes in living cells enables 
investigation of interactions in their normal environment. Bimolecular fluorescence 
complementation (BiFC) analysis is based on the formation of a fluorescent complex by 
fragments of fluorescent proteins, whose association is facilitated by an interaction between 
proteins that are fused to the non- fluorescent fragments. BiFC analysis enables visualization of 
protein interactions in living cells and organisms with minimal perturbation of the normal 
cellular environment.  
 
 
Figure 1.7:  Principle and  dynamics of bimolecular fluorescence complementation 
 
The most exciting feature of this method is that the complex can be directly visualized in living 
cells without the need for staining with exogenous molecules that could affect detection of the 
interaction. This system does not require structural information about the interaction partners, 
nevertheless, steric constraints can prevent association of the fragments within a complex which 
can be overcome by using peptide linkers between the fragments and the interaction partners. 
In this system interaction occurs in competition with mutually exclusive interactions with 
alternative interaction partners. A stable intermediate complex is formed on association of two 
non-fluorescent protein fragments that undergoes slow maturation to produce irreversible mature 
fluorophore complex, but sometimes in the presence of cellular chaperones might get 
dissociated.  The spectral characteristics of the bimolecular fluorescent complex are comparable 
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to that of the intact fluorescent protein. The fluorescence intensity produced by BiFC complexes 
in living cells is generally less than 10% of that produced by expression of an intact fluorescent 
protein, nevertheless, because autofluorescence is detected in the visible range similar to that of 
emitted by intact fluorescent proteins with the same excitation (514 nm) and emission maximum 
of 527nm. Fluorescent-protein fragments that have not associated with complementary fragments 
undergo irreversible misfolding in vitro thereby reducing any non-specific signals. 
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2. Aim 
 
‘Keratins’ – the largest subgroup of intermediate filament proteins, form a complex network of 
keratin filaments in the cytoplasm of epithelial cells provides stability and integrity thereby 
protecting the cells from mechanical and non-mechanical stress. The keratin family comprises 
more than 50 individual members (Hesse et al., 2001; Moll et al., 1982; Schweizer et al., 2006) 
which are expressed in a tissue type-restricted pattern and differentiation stage. This raises the 
question on functional importance of the multiplicity of keratin sequences according to their 
expression profile, and is supported by the recent findings revealing the key role of keratins in 
regulatory functions of the cellular machinery like organelle transport apart from its well 
established structural functions. Understanding the molecular mechanism by which keratins exert 
regulatory functions will help to know about the unidentified contributions of keratins and their 
extended role beyond scaffolding cytoarchitecture. 
To understand the novel functions of keratins, knowledge of keratin-associated proteins is a 
major pre-requisite. As a first step, this study was designed with the aim of identifying associated 
proteins of “K5 and K14”, followed by the characterization of identified keratin associated 
proteins. 
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 3. Materials and Methods 
 
3.1 Materials 
 
3.1.1 Chemicals used 
 
Unless otherwise stated, chemicals were purchased from Serva (Heidelberg, Germany), Sigma 
(Deisenhofen, Germany), Roche (Basel, Switzerland), Fermentas (St.Leon-Rot, Germany), 
Merck (Darmstadt, Germany), Fluka (Deisenhofen, Germany), Invitrogen Life Technologies 
(Karlsruhe, Germany), or Applichem (Darmstadt, Germany). 
All media base and salts for yeast culture were purchased from Becton, Dickinson and company, 
Sparks. MD21152 
All cell culture solutions, buffers, DNase I, antibiotics & normal goat serum were from Sigma 
(Deisenhofen, Germany), Invitrogen/Life technologies (Karlsruhe, Germany) & GibcoBRL 
(Karlsruhe). 
In vitro High Prime DNA labeling kit was from purchased from Roche (Basel, Switzerland). 
[α-32P]-dCTP was obtained from Amersham Biosciences (Buckinghamshire, UK). 
Restriction enzymes, protein and DNA markers dNTPs and NTP’s were from Fermentas 
(St.Leon-Rot,Germany). 
PCR reaction mix (Buffers, Taq polymerase enzyme, MgCl2), RT-PCR kit were purchased from 
Invitrogen/Life technologies (Karlsruhe, Germany). 
 
3.1.2 Ready-to-use solutions / reagents 
 
Acetic Acid 
Acrylamide solution (37.5:1) Acrylamide/Bisacrylamide for protein-SDS-gel 
Chloroform 
DAB substrate (Biogenex, DC138R006) 
Dimethylsulfoxide (DMSO) 
PBS- (Dulbecco’s Phosphate buffered saline) for cell culture 
Ethanol 
Ethidiumbromide, 10mg/ml 
Formaldehyde, 37 % 
Isopropanol 
Methanol 
ProLong® Gold antifade reagent (Molecular Probes, P36930) 
Roti-Phenol TE equilibrated for purification of nucleic acids 
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TEMED for protein-SDS gel 
TRIzol for isolation of RNA 
Taq-Polymerase (Invitrogen, 10342-020) 
Tween-20 
Triton-X100 
 
 
3.1.3 Kits 
 
High Prime DNA labeling system (Roche, 11585584001) 
QIAEX II Gel Extraction Kit (Qiagen, 20021) 
Nucleospin Plasmid for plasmid DNA miniprep (Macherey-Nagel, 740 588.250) 
Nucleobond AX for plasmid DNA midiprep (Macherey-Nagel, 740 410.100) 
Superscript II Reverse Transcriptase (Invitrogen, 18064-014) 
Protino Ni-IDA for recombinant protein purification (Macherey-Nagel, 745 210.5) 
 
3.1.4 Solutions for DNA analysis    
  
Name Final  Concentration Constituents and their amounts 
Sodium acetate 3 M  
40.82 g Sodium acetate in 100ml water. pH was adjusted 
5.2 with acetic acid and stored at room temperature. 
DNA loading Buffer
 
30% 
100 mM 
0.25% 
0.25% 
0.25% 
2% 
Ficoll Type 400 
3.72 g EDTA 
125 mg Bromphenolblue 
125 mg Xylenecyanol 
Orange G 
20% SDS 
Lysis buffer 
100 mM 
5 mM 
0.2% 
200 mM 
10 ml of 1 M  
Tris-HCl 
1 ml of 0.5 M EDTA 
1 ml SDS-solution, 20 % 
4 ml 5 M NaCl 
The above ingredients were added to 84ml of 
DNase/RNase free water and stored as 10ml aliquots at   
-20oC 
10 x TBE 
 
0.89 M 
0.89 M 
8 mM 
 
54 g Tris-base 
27.5 g Boric acid 
20 ml from 0.5 M pH 8 EDTA 
The solution was autoclaved and stored at room 
temperature. 
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20x SSC transfer 
buffer 
 
1.5 M 
0.5 M 
 
175.3 g NaCl 
88.2 g Sodium citrate 
pH was adjusted to 7.0 with a few drops of 10N NaOH 
solution. The volume was adjusted to 1L and sterilized 
by autoclaving. 
DNA denaturation 
solution 
 
0.4 M 
 
16 g NaOH in 1 L of water. Stored at room temperature.
Hybridization 
buffer 
 
50% 
5x 
5x 
1% 
0.1 mg/ml 
10% 
 
250 ml Formamid ultrapure. 
125 ml 20x SSC 
5ml 100x Denhardt’s solution  
25 ml 20% SDS 
5ml DNA, MB-grade; from fish sperm 10 mg/ml 
50 g Dextransulfate 
The contents were mixed and the volume was adjusted to 
500 ml with sterile water, aliquoted and stored at -20oC 
Proteinase K 
solution 
 
 
20 mg/ml 
 
 
1 g Proteinase K (Applichem, A38300025) was added to 
50 ml DNAase/RNAse free water, aliquoted and stored  
at -80°C. 
 
RNase 
Solution 
 
20 mg/ml 
 
500 mg RNase was dissolved in 25 ml DD water and 
heated for 15 min at 95oC. Aliquoted and stored at -80oC.
TBE (10 x) 
 
 
900 mM 
900 mM 
25 mM 
 
109 g Tris-base 
55.6 g Boric acid 
0.93 g EDTA 
Dissolved in 1L water and pH adjusted to 8.3 
TE buffer 
 
 
10 mM 
1 mM 
 
 
121 mg Tris 
37.2 mg EDTA 
Dissolved in 100 ml DD water, pH adjusted to 8.0 and 
sterilized by autoclaving. Stored at RT 
DNAse solution 
 
 
1 mg/ml 
50% 
50% 
 
 
3 mg DNAse I 
0.5 ml 0.3 M NaCl 
0.5 ml glycerol 
Stored at -20oC. 
β-Mercaptoethanol 
 
 
0.1 M 
 
 
69 μl of 14.4 M β-mercaptoethanol in 10 ml of DD water.
Stored at 4oC. 
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Pepsin stock 
solution 
 
 
10% 
 
1 g of pepsin dissolved in 10 ml of DD water. Stored 
 at –20oC. 
Pepsin working dilution: 50 μl pepsin stock solution was 
added to 70ml of DD water containing 700 μl of  
1 M HCl. 
10x PBS 
 
137 mM 
2.7 mM 
10 mM 
2 mM 
 
40 g NaCl 
1 g KCl 
89 g Na2HPO4.2H2O 
12 g KH2PO4 
Salts were dissolved in 4.5 L water, pH was adjusted to 
7.4 with HCl,and volume was adjusted to 5 L with water 
and autoclaved. Stored at RT. 
 
Magnesium 
chloride 
 
 
1 M 
 
 
101.65 g MgCl2 in 500 ml water. 
 
PBS Magnesium 
Chloride 
 
 
0.25 M 
 
 
5 ml 1 M Magnesium chloride 
95 ml 1x PBS 
Prepared fresh 
Table No 3.1.1: Solutions for DNA analysis  
 
 
3.1.5 Solutions for bacterial cultures 
 
Name 
 
Final 
Concentration
Constituents and their amounts 
Ampicillin 
solution 
 
5% 
 
50 g ampicillin in 50 ml of water. Sterile filtered. End 
concentration used was 100 mg/ml. 
LB Agar 
 
2% 
 
 
1 L LB Medium 
32 g LB Agar in 1 L water 
Sterilized by autoclaving. Antibiotics were added at 
55°C and plates were poured. 
 
LB Medium 
  
25 g LB medium was dissolved in 1 L water and 
sterilized by autoclaving. 
 
Table No 3.1.2: Solutions for bacterial cultures  
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3.1.6 Media and reagents for yeast two hybrid screening 
 
Name Final Concentration
Constituents and their amounts 
Synthetic Glucose 
Minimal Medium 
[SD/Glucose (–UL) 
 
 
1.7grams 
5 grams 
20 grams 
17grams 
 
Yeast nitrogen base without aminoacids 
Ammonium sulfate 
Dextrose 
Bacto agar for SD dropout agar plates 
Adjust the total volume to 900 ml with dH2O 
Autoclave for 15 minutes at 121°C, cool to 55°C. Add  
100 ml of the appropriate 
filter-sterilized 10× dropout solution 
 
Synthetic Galactose 
Minimal Medium 
[SD/Galactose (–UL)] 
(per Liter) 
 
 
1.7grams 
5 grams 
20grams 
10grams 
17 grams 
 
Yeast nitrogen base without aminoacid 
Ammonium sulphate 
Galactose 
Raffinose 
Bacto agar for SD dropout agar plates 
Adjust the total volume to 900 ml with dH2O. Autoclave 
for 15 minutes at 121°C, cool to 55°C. Add 100 ml of 
the appropriate filter-sterilized 10× dropout solution 
Cell Lysis Buffer for 
Protein 
Isolation 
 
 
140 mM 
2.7 mM 
10 mM 
1.8 mM 
1 % 
 
1 mM 
10 μg/ml 
1 μM 
100 μM 
1 μg/ml 
 
NaCl 
KCl 
Na2HPO4 
KH2PO4 
Triton® X-100 containing freshly added 
Protease inhibitors: 
PMSF 
aprotinin 
pepstatin A 
leupeptin 
chymostatin 
 
LB– Chloramphenicol 
Agar 
(per Liter) 
 
 
3 ml of 10-mg/ml
Prepare 1 liter of LB agar Autoclave. Cool to 55°C 
Add -filter-sterilized chloramphenicol 
Pour into petri dishes (~25 ml/100-mm plate) 
 
 
1.4 M β-ME (yeast 
competent cells) 
 
  
Dilute stock -mercaptoethanol 1:10 with 
sterile dH2O just prior to use 
 
NaOH/β-ME Buffer 
 
 
1.85 M 
 
NaOH 
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7.5% β-Mercaptoethanol 
Salmon Sperm DNA 
 
20 mg/ml 
 
 
Boil 400 μl of  sheared salmon sperm DNA for 10 
 minutes 
LiSORB (per Liter) 
 
100 mM 
10 mM 
1 mM 
1 M 
 
LiOAc 
Tris-HCl (pH 8.0) 
EDTA 
sorbitol 
Add dH2O to a volume of 1 liter Verify that the  
pH is 8.0 Autoclave. Store at room temperature 
 
PEG/LiOAc Solution 
 
 
10 mM 
1 mM 
100 mM 
40% (w/v) 
 
 
Tris-HCl (pH 8.0) 
EDTA (pH 8.0) 
LiOAc (pH 7.5) 
PEG 3350. Autoclave 
YPAD Agar (30–40 
Plates/Liter) 
 
 
1% 
2% 
2% 
2% 
40 mg 
 
 
yeast extract 
Bacto peptone 
dextrose 
Bacto agar 
adenine sulfate 
Autoclave at 121°C for 20 minutes Pour into petri dishes 
(~25 ml/100-mm plate) Dry plates at room temperature  
for 2–3 days Store plates in a sealed bag 
SU Buffer 
 
5% 
8 M 
125 mM 
0.1 mM 
0.005% (w/v) 
 
(w/v) SDS 
Urea 
Tris-HCl (pH 6.8) 
EDTA 
bromophenol blue 
Store at –20°C Add 15 mg of DTT/ml of SU  
buffer prior to use. 
 
YPAD Broth 
 
1% 
2% 
2% 
40 mg 
 
yeast extract 
Bacto peptone 
dextrose 
adenine sulfate 
Add deionized H2O to a final volume of 1 liter 
Autoclave at 121°C for 20 minutes 
 
Yeast Lysis Solution for 
DNA 
Isolation 
2.5 M 
50 mM 
LiCl 
Tris-HCl (pH 8.0) 
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 4% 
62.5 mM 
Triton X-100 
EDTA 
 
Table No 3.1.3: Solutions for yeast cultures 
 
 
3.1.7 Solutions for protein biochemistry 
 
Name 
 
Final 
Concentration 
Constituents and their amounts 
 
5x Laemmli 
sample 
buffer 
 
50 mM 
5% 
40 mM 
5 mM 
5 mM 
20% 
0.01% 
 
Sodium phosphate pH 6.8 
SDS 
DTT 
EDTA 
EGTA 
Glycerol 
Bromophenol blue 
Solution was stored at -20oC and freeze/thawed not more 
than 5 times. 
APS  10% 
 
1g Ammonium persulphate in 10ml water. 
Stored at 4oC for not longer than 1 month. 
Stacking gel 
buffer (Upper 
Tris) 
0.5 M 
0.4% 
15.1 g Tris-base 
1 g SDS 
Volume made up to 250 ml after adjusting pH to 6.8,  
sterile filtered and stored at 4oC. 
Separating 
gel buffer 
(Lower Tris) 
 
1.5 M 
0.4% 
 
181.7 g Tris 
4 g SDS 
Volume made up to 1 L after adjusting to pH 8.8, sterile 
filtered and stored at 4oC. 
SDS-running 
buffer (1x 
Laemmli 
buffer) 
 
23 mM 
190 mM 
0.1% 
 
2.78 g Tris Base 
14.26 g Glycine. 
5 ml 20% SDS stock 
The contents were mixed in 1 L water and pH was  
adjusted to 8.8. Stored at room temperature 
Coomassie 
Staining solution
 
0.4% 
5 % 
40% 
 
1.0 g Coomassie Brilliant Blue G-250. 
25 ml Acetic Acid 
200 ml Methanol 
Volume was adjusted to 500 ml with distilled water,  
filtered through a Whatmann filter paper and stored at 
room temperature. Solution was used more than once. 
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Coomassie 
destaining 
solution 
 
10% 
30% 
50 ml Acetic Acid 
150 ml Methanol 
Solution made up to 500 ml with water. 
 
Ponceau  
staining 
solution 
 
0.5% 
1% 
 
0.5 g Ponceau S 
1 ml Acetic acid 
Contents were dissolved in 100 ml distilled water and 
filtered; Solution was stored in dark at room temperature. 
 
Transfer 
buffer (1x 
Towbin 
buffer) 
 
25 mM 
192 mM 
0.1% 
10% 
 
3.028 g Tris. 
14.41 g Glycine 
1 g SDS 
100 ml Methanol 
The contents were dissolved in 1 L water, and pH was 
adjusted to 8.3. Solution was stored at room temperature 
10x Tris 
buffered 
saline (TBS) 
 
0.1 M 
1.5 M 
 
12.1 g Tris 
87.6 g NaCl 
Contents were dissolved in 750 ml water, pH was adjusted 
to 7.5 and the volume was made up to 1 L. Solution was 
sterilized by autoclaving and stored at room temperature. 
Western 
washing 
buffer 
 
1x 
0.1% 
 
100 ml 10x TBS. 
1 ml Tween 20 
Volume was made up to 1 L with water 
Blocking 
solution 
 
5% 
1x 
0.5% 
 
5 g Skimmed milk (Sucofin). 
100 ml 10x TBS 
1 ml Tween 20 
Always prepared fresh 
Alternative 
blocking 
solution 
 
 
5% 
1x 
0.5% 
 
5 g BSA fraction V. 
100 ml 10x TBS 
1 ml Tween 20 
Always prepared fresh 
Protease 
inhibitor 
 
1x 
 
Complete Protease Inhibitor Cocktail Tablets. 7 x stock 
solution was prepared by dissolving one tablet in 1.5 ml 
water, aliquoted and stored up to 6 months at -20°C. 
Phosphatase 
inhibitor 
 
1x 
 
Phosphatase Inhibitor Cocktail Tablets. 10 x stock solution
was prepared by dissolving one tablet in 1 ml water, 
aliquoted and stored up to 6 months at -20°C. 
Table No 3.1.4: Solutions for protein biochemistry 
 
 
 
 
 
 
 
 - 28 -
  Materials and Methods 
3.1.8 Bacterial strain 
 
Description 
 
Characteristics and Application 
 
E. coli XL1- 
blue MRF 
 
 
RosettaBlue(DE3)pLysS  
Genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 
lac [F´ proAB lacIqZΔM15 Tn10 (Tetr)] ; Amplification of plasmid 
endA1 hsdR17 (rK12- mK12+) supE44 thi-1 recA1  
gyrA96 relA1 lacF' [proA+B+ lacIqZΔM15::Tn10(tetR)] 
(DE3)pLysSRARE (CmR) 
Table No 3.1.5: Bacterial strain genotype 
 
3.1.9 Yeast strain 
 
Host strain Genotype 
cdc25H Yeast Strain 
(α) 
MATα ura3-52 his3-200 ade2-101 lys2-801 trp1-901leu2-3 112 
cdc25-2 Gal+ 
Table No 3.1.6: Yeast strain genotype 
 
 
3.1.10 Primers 
 
Name Sequence Product 
BN1019 
pSos-K5HD 
–-Fwd 
5` ATATGGATCCATGGAGCGCGAGCAGATCAAGACC 3` 
BN1020 
pSos -K5HD 
–Rev 
5` ATATGTCGACCTACTCGCCCTCCAGCAGCTTGCG 3` 
Keratin5 head 
domain 
BN1021 
pSos-K14HD 
–Fwd 
5` ATATGGATCCATGGAATGCAGACTCAGTGGAGAA 3` 
BN1022 
pSos-K14HD 
–Rev 
5` ATATGTCGACCTAGAACACATTCTGGAGGTAGTT 3` 
Keratin14 head 
domain 
BN1186 
pSos-K5RD-
Fwd 
5’ ATATGGATCCATGGAGCGCGAGCAGATCAAGACC 3’ 
BN1187 
pSos-K5RD-
Rev 
5’ TATGCGGCCGCTCACTCGCCCTCCAGCAGCTT 3’ 
Keratin5 rod domain 
BN1188 
pSos-K5TD-
Fwd 
5’ TATGGATCCAGATGGAATGCAGACTCAGTGGA 3’ 
 
BN1189 
pSos-K5TD-
Rev 
5’ ATATATGCGGCCGCTTAGCTCTTGAAGCTCTT 3’  
 
Keratin5 tail domain 
BN1190 
pSos- 5’ ATATGGATCCAAGGTGACCATGCAGAACCT 3’  
 
Keratin14 rod 
domain 
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K14RD-fwd 
BN1191 
pSos-
K14RD- Rev 
5’ ATATATGCGGCCGCTCAGAGGTGGGCGTCCTCGCC 3’ 
BN1192 
pSos-
K14TD- Fwd 
5’ ATAAGGATCCCACCTCATGTCCTCCTCCCAGTCC 3’  
 
BN1193 
pSos-
K14TD- Rev 
5’ ATATATGCGGCCGCGCCTCAGTTCTTGGTGCGAAG 3’ 
Keratin14 tail 
domain 
BN1090 
Rab34HA-
tag-C e/s 
Fwd 
5’GCGGCGAGTCGACCCGCAGGCAGGATGAACATTCTG  3’
  
 
BN1091 Rab 
34 HA-tag-C 
e/s FP WIK 
Kpn I 
 
5’ ATAATCCGGTACCCAGGCAGGATGAACATTCTG 3’  
 
Rab34 
BN1115 
AP2ß HA-
tag-C e/s RP 
5’ ATTATATGGTACCGTCATTTCCTGTGTTTCTCCTC 3’ 
 AP2β 
hZwi-V1/2-
FL/HA 5' ATATGTCGACAGCTTTGTGGTGGTGCCATG 3' 
hZwi-V1/2-
FL/HA rev 5' ATA TCG GTA CCC TCA AAC TGT AGA CTG GTC 3' 
p86DM 
pV1-N Zwi 
fwd  5' ATATAAAGCTTTGTGGTGGTGCCATGCAGCAAGAA 3' 
pV1-N Zwi 
rev  5' ATATCGGTACCACTGTAGACTGGTCTCT 3' 
p86DM 
Table No 3.1.7: List of primers used to prepare constructs 
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3.1.11 Plasmids 
 
 
 Expression vector Description 
1 pSos 
contains DNA encoding amino acids (aa) 1 to 1067 of the 
hSos gene and unique 3´ cloning sites. It is used for 
constructing a bait plasmid containing a DNA insert 
encoding a bait protein 
2 pMyr 
contains DNA encoding the myristylation membrane 
localization signal (Myr) and unique 3´ cloning sites and is 
used for constructing plasmids or cDNA libraries that 
contain DNA inserts encoding target proteins 
3 pSos MAFB 
expresses the Sos protein and full-length MAFB as a 
hybrid protein 
4 pSos Cadherin expresses fused Sos protein and full-length cadherin 
5 pSos Col I 
expresses fused Sos protein and amino acids 148–357 
of murine 72-kDa type IV collagenase 
6 pMyr armadillo 
expresses the myristylation signal fused to full length 
armadillo protein 
7 pMyr MAFB 
expresses a hybrid protein that contains the 
myristylation signal fused to full-length MAFB 
8 pMyr SB 
expresses the myristylation signal fused to a Sos-
binding protein 
9 pMyr lamin C 
expresses the myristylation signal fused to amino acids 
67–230 of human lamin C 
10 pVen1-Flag-C E/S 
contains amino terminal half of Venus YFP tagged with 
FLAG tag 
11 pVen2-HA- C E/S 
contains carboxy terminal half of Venus YFP tagged 
with HA tag 
12 pVen1-N E/S contains amino terminal half of Venus YFP 
13 pVen2-N E/S contains carboxy terminal half of Venus YFP 
14 pET-SUMO used for expression of recombinant p86DM 
Table No 3.1.8: List of plasmids 
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3.1.12 Antibodies 
 
Name Antigen/ 
Anti-species 
Source Subclass Dilution/ 
Application 
Source 
Anti-
GFP 
GFP Mouse Monoclonal 
IgG2a 
1/500, 
Immunofluoresence 
 
Abcam 
Zwi-3 p86DM Guinea pig  1/2000, 
 Immuno blotting 
 
In-house 
Alexa 
594 
Mouse Goat IgG H+L  1/400, 
Immunofluoresence 
Molecular 
probes 
Alexa 
488 
Mouse Goat IgG H+L 1/400, 
Immunofluoresence 
Molecular 
probes 
HRP Mouse Goat  1/30,000,  
Immuno blotting 
Molecular 
probes 
HRP Guinea pig Goat  1/30,000,  
Immuno blotting 
Molecular 
probes 
Table No 3.1.9: List of antibodies 
 
 
3.1.13 General Lab Materials 
 
All sterile cell culture plastic-ware were purchased from Falcon, Sarstedt, Nunc and Becton 
Dickinson 
Pipette Tips and tubes were purchased from Sarstedt 
Fuji Medical X-Ray film (Fuji) 
High density photopaper (Mitsubishi) 
Hybond-N- blotting membrane 30cm x 3m (Amersham, RPN303B) 
Microscope slides 76 x 26 mm (Engelbrecht) 
Protran Nitrocellulose Hybridization Transfer Membrane, 0.2 μm, 30 cm x 3 m Roll 
(Schleicher &Schuell) 
Sterile filters 0.45 μm, 0.2 μm, 0.1 μm (Schleicher & Schuell) 
SuperFrost® Plus microscope slides (Menzel #041300) 
Universal agarose 
Whatman 3mm-Paper GB 002 (Schleicher & Schuell #426693) 
Whatmann filter paper (Schleicher & Schuell) 
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3.1.14 Equipment and materials used 
Instrument / Software Model / Version Company 
Agarose gel electrophoresis 
system  
B2; B1A Angewandte Genetechnologie 
Blotting Chamber  Fast blot B49 Biometra 
Centrifuges  5417R, 5810R, 5417C Eppendorf 
CO2 incubator  CB150; CB210 Binder 
Film Developer  Curix 60 Agfa 
Fluoresence Microscope  AxioPhot II Zeiss 
Incubators for bacterial / yeast 
cultures  
Function line Heraeus Instruments 
Inverted tissue culture 
microscope 
Telaval 31 Zeiss 
Laminar flow system-type  Herasafe Heraeus Instruments 
PCR-Thermocycler  TGradient Biometra 
pH-Meter  761 Calimatic Knick 
Scintillation counter  Beckmann LS-6500 Beckmann 
UV-spectrophotometer  Genesys 10UV Thermoelectron corporation 
Water purifier  Milli-Q Plus Nanopure Barnstead 
Electroporator  Gene Pulser II Biorad 
Table No 3.1.10: List of equipments 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 33 -
  Materials and Methods 
3.2 Methods 
3.2.1 Molecular biological methods 
 
3.2.1.1 Polymerase Chain Reaction 
Unless specified differently, PCR reactions were performed in a total volume of 25μl. To avoid 
nonspecific annealing of the primers and undesired PCR amplification, all the constituents 
(Table No. 3.2.1) were pipetted on ice and transferred to a cycler (iCycler, BioRad) immediately. 
The PCR was performed along with corresponding positive and negative controls. For multiple 
PCR reactions, a master mix was made and respective templates were added in appropriate 
aliquots of master mix. 
 
PCR condition optimization Taq polymerase enzyme 
 
PCR conditions (20 μl PCR   PCR programme : 
 master mix)     
Step Temperature Time Cycles
5 min 1  Denaturation
 95.0°C 30sec 
Annealing 
59.2°C, 60.4°C
61.6°C 62.8°C
64.0°C 65.1°C
30 sec 
Extension 72.0°C 60 sec per kb 
35 
Final extension 72.0°C 10 min 1 
Storage 4.0°C 
1.0 ng Template DNA (linearised 
plasmid) 
2.5 μl 10x PCR buffer 
0.75 μl MgCl2 (50mM) 
1.0 μl dNTP’s (5mM) 
1.0 μl fwd sense primer 
1.0 μl rev anti-sense primer 
∞ 0.2 μl (IU) Taq polymerase 
13.55 μl water    
       Table 3.2.1: PCR program for optimization of conditions using  
       Taq polymerase enzyme  
 1 
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PCR amplification using proof reading Taq polymerase enzyme 
 
PCR conditions (20 μl PCR   PCR programme : 
 master mix) 
10.0 ng (1.0 μl) Template DNA 
(linearised plasmid) 
Step Temperature Time Cycles 
5 min 1 Denaturation
 95.0°C 30sec 
Annealing 
X°C from 
optimization 
reaction 
30 sec 
 
Extension 72.0°C 60 sec per kb
20 
Final extension 72.0°C 10 min 1 
Storage 4.0°C ∞  1 
 5.0 μl 5x high fidelity PCR buffer 
with MgCl2 (50mM) 
1.0 μl dNTP’s (5mM) 
1.0 μl fwd sense primer 
1.0 μl rev anti-sense primer 
0.25 μl (IU) Taq polymerase 
10.75 μl water   Table 3.2.2: PCR program for optimization of conditions using      
proof reading Taq polymerase enzyme  
 
3.2.1.2 Ligation of PCR products 
PCR products were ligated with the TOPO® cloning kit (Invitrogen). To avoid auto degradation 
of adenosine overhangs upon longer storage intervals, freshly prepared PCR products were used. 
If blunt end producing (3´-5´ exonuclease activity, proof reading activity) polymerase was used, 
the ligation was carried out using the Zero Blunt® TOPO® PCR cloning kit (Invitrogen). The 
ligation was done according to the manufacturer's directions. 
 
3.2.1.3 Transformation and culture of E. coli 
The ligation product (2 μl) was mixed with 20 μl of competent E. coli (XL1 blue) and incubated 
on ice for 30 min. The cells were heat shocked at 42°C for 90s and were quickly placed on ice 
for 2 min. 500 μl LB medium was added and cells were incubated in a bacterial shaker at 37°C 
for 1 h. The cells were spread on LB-plates with respective antibiotic.  
After 14-20 h of incubation at 37°C, colonies were chosen and kept for overnight cultures in 5 
ml LB-growth medium with the respective antibiotic. 
 
3.2.1.4 Preparation of plasmid DNA 
3.2.1.4.1 Plasmid DNA isolation (mini preparation) 
For analytical purposes, 5 ml of overnight bacterial culture was used. The plasmids were isolated 
using silica columns according to manufacturer's instructions (NucleoBond PC20, Machery-
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Nagel). 
 
3.2.1.4.2 Preparative Plasmid DNA isolation (midi/maxi preparations) 
For preparative purposes, 50 ml - 100 ml of overnight bacterial culture was used. The plasmids 
were isolated with silica columns according to manufacturer's instructions (NucleoBond PC100, 
Machery-Nagel). 
 
3.2.1.5 DNA restriction digestion 
Digestions of DNA with restriction endonucleases were performed according to the instructions 
given by the manufacturer (Fermentas Life sciences). 
 
3.2.1.6 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to resolve DNA constructs. Agarose gels were casted in 
TAE Buffer. 0.5 μg/ml ethidium bromide was added while casting gel. DNA samples were 
diluted in 10x loading dye before loading on agarose gels. One kb and 100 bp molecular weight 
ladders (Invitrogen) were used to analyze the molecular size of the DNA. Gels were run at 80-
120 V in TAE buffer.  
 
3.2.1.7 Isolation of DNA fragments from agarose gel 
Under UV-light desired bands were cut out from the gel using a sterile scalpel. DNA was 
extracted from the agarose using the Qiagen gel extraction kit. 
 
3.2.1.8 DNA precipitation in ethanol / isopropanol 
Ethanol and isopropanol precipitation was used for the purification of DNA and RNA. Ionic 
concentration of the aqueous DNA and/or RNA solution was increased by addition of 1/10 
volume 3 M sodium acetate solution (pH 5.2). About 2.5 times volumes of ethanol/isopropanol 
were added. The DNA and/or RNA was incubated at -20°C for 30-60 min. Afterwards the 
sample was centrifuged at 14,000 rpm, the pellet was washed with 70% ethanol and dried for 10 
min at 60°C. Then the DNA and/or RNA pellet was dissolved in the desired quantity of Sigma 
water or TE buffer pH 8.0 
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3.2.1.9 Concentration determination of nucleic acids 
To determine the concentration of DNA or RNA in a solution the optical density (OD) was 
measured. Nucleic acids have an absorption maximum at 260 nm and proteins absorb UV light 
maximally at a wavelength of 280 nm. An OD unit corresponds to the amount of nucleic acid in 
µg in a 1 ml volume using a 1 cm path length quartz cuvette that results in an OD260 reading of 
1. 
    For DNA OD260 1 = 50 mg / ml, 
    For RNA OD260 1 = 40 mg / ml, 
    For single stranded oligonucleotides OD260 1 ~ 33 mg / ml 
The ratio of readings taken at 260 nm and 280 nm wavelengths indicates of the purity of the 
nucleic acid. 
     For pure DNA OD260/OD280 = 1.8 
    For pure RNA OD260/OD280 = 2.0 
 
3.2.1.10 Sequencing of DNA 
The sequencing of plasmids was performed by the Macrogen Incorporations in Seoul (South 
Korea). 
 
3.2.1.11 Southern blotting 
Rod domains of Keratin 5 and 14 were amplified by PCR and obtained 929bps and 932bps 
amplified product respectively. The PCR products were loaded on a 0.7% agarose gel in 1x 
TBE- buffer with 0.5 μg/ml ethidiumbromide.  The samples were run for about 400- 700 Vh 
with a maximum of 80 V. Photograph of the gel was taken by exposing to limited UV. Gel 
was incubated 30- 40 min in 0.4 M NaOH and Hybond N+ and 3 sheets of filter paper were 
kept. Buffer reservoir with 300- 400 ml 20x SSC - 2x filter papers - Gel – membrane - 2x 
filter paper - pile of paper cloths - glass plate- about 200 g- weights were used. Transfer was 
carried out and then the membrane was removed carefully and the gel run was marked with a 
pencil. Membrane was washed for 15 seconds in 2 x SSC and dried totally on filter paper.  
DNA present on the membrane was baked at 80°C for 2 h or can be UV cross linked for ~30 
sec (0.16kJ/m2). The membrane was washed with 5X SSPE and then incubated in 25 ml 
hybridization buffer for 30 min (or longer – maximum overnight) at 42°C.  In the meantime 
probe was prepared. Labeling of the probe was done using dCTP. 25ng of DNA is mixed with 
10 μl of buffer and made up to 40μl with water. The sample is kept in boiling water bath for 
10 mins and snap cooled in ice. To the snapped chilled sample 3 µl MixC (dNTP without 
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dCTP), 5µl radioactive labelled dCTP, 1µl Klenow enzyme was added and incubated at 37°C 
for 5mins.To the above sample 4μl of dNTP was added and incubated at 37°C for 10 mins 
and the reaction was stopped by the addition of 1μl EDTA (0.5M). The sample is made to 
200μl with TE and then to that 400μl of 70% Ethanol, 40 µl NaAcetate, 1µl glycogen. Spun 
for 15 min 14.000 rpm in room temperature and the supernatant was collected for scintillation 
counter. The pellet was washed twice with 70% ethanol and dissolved in 50μl Sigma water. 
1μl was taken into counter.  
Calculation:  
counts supernatant + counts probe = counts total (~ 50-60 Mio in 5µl fresh dCTP). 
Incorporation rate = counts probe / counts total.  
Salmon sperm DNA (100 µg/ml hybridization solution) was added to the hybridization tubes 
containing the labeled probe and incubate 5 min at 95°C before adding probes. Spun briefly 
for a few seconds and the probe were added to the hybridization tubes (do not add directly on 
membrane) followed by incubation at 42°C for at least 16 h. After the hybridization, 
membrane was washed for Wash 20- 30 min at 68°C in the shaking water bath with 300 ml of 
pre-warmed washing solution. Exposed along with StrataLogos. 
 
3.2.1.12 Isolation of RNA 
For the isolation and the analysis of RNA some precautionary measures were followed. For all 
buffers and solutions sterile milli Q water was used. All used glassware was baked for at least 4 
h at 180°C before use. Metallic parts such as spatulas, pincets or the homogenizer were washed 
thoroughly with RNase off and followed by sterile milli Q water. The RNA was isolated with 
TRIzol reagent (Invitrogen). 1 mL TRIzol reagent was used per 10 cm2 cultured dish. The 
suspension was homogenized in TRIzol reagent with a homogenizator (T8 ultra turrax, IKA) and 
passed through a 21 G needle at least 10 times. Homogenized samples were left at room 
temperature for 5 min in 2 ml eppendorf tubes to allow complete dissociation of nucleoprotein 
complexes. The homogenate was centrifuged at 5,000 rpm at 4°C for 5 min. The supernatant was 
then mixed with 1/10 volume 1-Bromo-3-chloro-propane by vortexing. The mixture was 
incubated for 3 min and centrifuged at 4°C at 14,000 rpm. The aqueous phase was carefully 
transferred into a fresh tube and mixed with an equal volume isopropanol and incubated for 10 
min. Afterwards the sample was centrifuged at 4°C at 14,000 rpm. The resulting RNA pellet was 
washed with 75% ethanol. The pellet was dried in air for 10-15 min and dissolved in milli Q 
water by incubating 15 min at 55°C. The RNA concentration was estimated by reading O.D. 
using the Genesys 10uv. 
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3.2.1.13 Amplification of p86DM by RT-PCR from isolated RNA  
For the reverse transcription reaction, 1 μg total RNA isolated from Caco-2 cells was 
incubated with 20 pmol of oligonucleotide primers at 70°C for 10 min. After a short cooling 
on ice, 1x first strand buffer, 10mM dithiothreitol, 1 mM dNTP’s, 20 U of RNAsin (1U) were 
added to a total volume of 19 μl with RNase free water, mixed and incubated at 42oC for 2 
min. 200 U of Superscript II reverse transcriptase was added to the reaction mix, mixed by 
pipetting up and down and incubated at 42°C for 50 min. The reaction was stopped by 
incubating the reaction at 72oC for 15 min. The reaction mix was taken directly for the PCR 
reaction. PCR was performed in a 25 μl reaction mixture containing 1 μl of template cDNA, 
as detailed in section 3.2.1.1. 
 
3.2.2 Cell culture methods 
Common cell culture methods 
All cell lines were cultivated at 37°C in an incubator with 5% CO2 and humid atmosphere. 
Adherent growing cells were grown in tissue culture dishes on 6 or 10 cm diameter dishes.  
 
3.2.2.1 Passage of mammalian cells 
Almost confluent (80-90%) grown cells were passaged into a new culture dish. First the medium 
was removed and cells were washed with 10 ml PBS. Approximately 2 ml of a trypsin/EDTA 
solution (Invitrogen) were added and the plate was incubated at 37°C for 3-5 min to dislodge the 
cells. Trypsinization was inhibited by addition of 5 ml growth medium. Cells were mixed well 
by pipetting up and down with a 10 ml glass pipette and transferred into a Falcon tube. The cells 
were pelleted by centrifugation (1,200 rpm, 2 min), resuspended in growth medium and seeded 
at suitable density. 
 
3.2.2.2 Freezing and storage of cells 
A 15 cm confluent culture dish was passaged as above. Cells were resuspended in 5 ml freezing 
medium with 10% DMSO and transferred with a sterile 1 ml pipette in cryotubes. The cells were 
stored overnight at –20°C prior to -80°C long term storage.  
 
3.2.2.3 Thawing of cells 
Cells were thawed in a 37°C water bath as quickly as possible. In order to minimize the toxic 
effect of the DMSO, 5 ml fresh growth medium were added and cells were pelleted by 
centrifugation at 1,200 rpm for 2 min. The cell pellet was resuspended in the appropriate cell 
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culture medium and seeded depending upon desired cell density in tissue culture dishes and 
cultivated under standard conditions. 
 
3.2.2.4 Cell counting 
The cell number was determined using a Neubauer modified cell chamber. The cell number per 
ml was calculated by determining the average number of cells in the 4 large squares and 
multiplying by 104. 
 
3.2.2.5 Transient transfection of eukaryotic cells 
Cells were grown to 60-80% confluence before transient transfection. Transfection was 
performed using Lipofectamine reagent (Invitogen) according to the manufacturer's instructions.  
 
3.2.2.6 Immunocytochemistry 
Transiently transfected cells were cultured on glass cover slips to 50-80% confluence. Cells were 
fixed in 4% paraformaldehyde for 10 min followed by permeabilization with 0.1% Triton X-100 
for 10 min and blocking with 5% BSA for 1 h. Cells were incubated with desired primary 
antibody/antibodies, for 2 h in 1% BSA. Primary antibodies were detected by using conjugated 
secondary antibodies diluted as per the manufacturer’s instructions. Coverslips were mounted on 
glass slides using 15% Mowiol mounting medium. Images were acquired on a fluorescence 
inverted microscope (Zeiss). 
 
3.2.3 Screening of keratin associated proteins using Sos recruitment system 
3.2.3.1 Establishing streaked yeast agar plate 
Cells were obtained from the glycerol stock by scraping off splinters of solid ice with a sterile 
wire loop or sterile inoculating stick. Splinters were streaked on an YPAD agar plate. 
The plate was incubated at room temperature (22–25°C) until colonies appeared (~4 days). 
 
3.2.3.2 Preparation of - 80°C yeast glycerol stock 
Single colony grown on YPAD agar plate was inoculated in 10ml of YPAD broth and were 
grown to late log phase (OD600 = 0.8–1.0) at room temperature (22–25°C). 4.5 ml of a sterile 
solution of 50% glycerol in liquid YPAD (prepared as 5 ml of glycerol + 5 ml of YPAD 
broth) was added to the yeast culture from step with continuous mixing. Glycerol-containing 
cell suspension was aliquoted into sterile centrifuge tubes (1 ml/ tube) and stored at –80°C.  
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3.2.3.3 Verification of yeast host strain marker phenotype 
Yeast from the –80°C glycerol stock was streaked onto each of the four agar “dropout” 
(tryptophan (Trp), leucine (Leu), histidine (His), and uracil (Ura)) plates and the plates were 
incubated at room temperature (22–25°C) for 4–6 days. Simultaneously sample of the same 
glycerol stock was streaked onto a YPAD agar plate and incubated at room temperature (22–
25°C) for 4–6 days. After the phenotype has been verified (growth on the YPAD plate and no 
growth on any of the four SD agar dropout plates), colonies from the YPAD plate were used 
for the preparation of competent yeast cells.  
 
3.2.3.3 Preparation of cdc25H yeast competent cells 
In the preparation of the competent cell, if revertants have arisen, then it is not suitable for two-
hybrid screening experiments. Fresh plate of cdc25H (aor α,) was prepared from the glycerol 
stock by scraping off splinters of solid ice with a sterile wire loop and streaked the splinters 
onto a YPAD agar plate. Plate was incubated at room temperature (22–25°C) until colonies 
appeared (~4   days).  4–5 cdc25H yeast colonies were picked (from a plate that is less than one 
week old) into separate 1.5-ml microcentrifuge tubes containing 1 ml YPAD. Cell clumps were 
completely dispersed by vortexing and yeast cell suspensions were diluted to 50 ml with YPAD 
followed with incubation for 14–16 hours at room temperature (22–25°C) with shaking at 220–
250 rpm till the OD600 of the cultures was >1. 
Cultures were diluted for a total diluted culture volume of 300 ml (OD600=0.2) and 
incubated at room temperature (22–25°C) with shaking at 220–250 rpm for 3 hours 
(OD600>0.7). 75 µl (approximately 1 × 106 cells) of each culture was plated on YPAD 
agar plate, sealed and incubated at 37°C. The plates were observed daily for 4–6 days, 
checking for temperature-sensitive revertants. Plates  with more than 30 colonies after 6 
days of incubation were discarded. 
Remaining volume of the yeast cultures was pelleted by centrifugation at 1000×g for 5 
minutes at room temperature, yeast cell pellets were resuspended in 50 ml of dH2O and spun at 
1000×g for 10 minutes at room temperature. Supernatant was discarded and the pellet was 
resuspended in 50 ml of LiSORB followed by incubation at room temperature for 30 minutes. 
At the end of the 30-minutes incubation, yeast cells were pelleted by spinning at 1000 × g for 
5 minutes at room temperature and resuspend in 300µl of LiSORB. 600 µl of sheared salmon 
sperm DNA mixture was added to the 300 µl of yeast cells from the previous step. Mixed 
thoroughly, to each cell preparation 5.4ml of PEG/LiOAc solution and 530 µl of DMSO was 
added and mixed. Cells were aliquoted in volumes of 500µl and 100µl in separate micro 
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centrifuge tubes. 
 
3.2.3.4 Transforming yeast and detecting protein-protein interactions 
 
Yeast transformation mixtures were prepared as outlined in Table No: 3.2.3. Plasmid DNA 
was added in the combinations listed to separate aliquots of freshly prepared cdc25H yeast 
competent cells. 2 µl of 1.4 M β-mercaptoethanol was added to each tube and mixed the contents 
thoroughly but gently by inversion or tapping. 
Transformation suspensions were  incuba ted  at room temperature for 30 minutes with 
occasional tapping. Cell suspensions were subjected to heat-shock treatment by incubating the 
transformation suspensions at 42°C for 15 minutes. Placed immediately on ice and left for 3 min. 
Cells were collected by centrifugation for 30 seconds at 14,000 rpm at room temperature and 
the supernatant was discarded. Cells were resuspended in 0.5 ml of 1 M sorbitol. Each of the 
transformation mixture was spread on agar plates using sterile glass beads as indicated in Table 
No: 3.2.3. For transformation group1, 10 µl and 100 µl of the cells we r e  p l a t e d  on 
separate 150 mm SD/glucose (–UL) agar plates and incubated these plates at room 
temperature (22–25°C). These platings were used to determine cotransformation efficiency. 
Remainder of transformation reaction 1 was plated on a150-mm SD/glucose (–UL) agar plate 
and Incubated at 37°C, this plate was observed daily for 4–6 days to check for temperature-
sensitive revertants. 
After incubation of this plate 37°C for 4–6 days, observed for any growth of colonies ( no 
colonies should appear. Colonies present on this plate indicate that the cells used for the 
transformation contained temperature-sensitive revertants or were not cdc25H). 
Transformation efficiency for the competent cell preparation was evaluated if the reversion 
control plates met the above criteria. Number of colonies on plates from transformation group1 
(Table No: 3.2.3) incubated at room temperature (22–25°C) were counted. Cotransformation 
efficiency was calculated using the following equation (The transformation efficiency should be 
at least 0.5 × 103–1 × 104 cfu/µg). 
 
For transformations 2–12, the entire transformation reaction mixture was plated on a 100-mm 
SD/glucose plate (either SD/glucose (–U), SD/glucose (–L) or SD/glucose (–UL) according to 
Table No: 3.2.3). Incubated at room temperature (22–25°C) until colonies were seen (4–6 days). 
Three colonies from each of these transformations (5–8, and 10-12) were selected for transfer to 
SD/glucose (–UL) and SD/galactose (–UL) to test for protein-protein interactions that allow  
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Number 
 
Plasmid(s) 
 
Amount of 
Plasmid 
 
Volume of Yeast 
Competent Cells 
Medium for 
Plating 
1 pSos + pMyr 2 µg each 
 
500  µl SD/glucose (–UL)
 
2 pSos MAFB 100  ng 100  µl SD/glucose (–L) 
 
3 pMyr SB 100  ng 100  µl SD/glucose (–U)
 
4 pMyr Lamin C 100  ng 100  µl SD/glucose (–U)
 
5 pSos MAFB + 
pMyr MAFB 
300  ng each 
 
100  µl 
 
SD/glucose (–UL)
 
6 pSos MAFB + 
pMyr Lamin C 
300  ng each 
 
100  µl 
 
SD/glucose (–UL)
 
7 pSos Col I + 
pMyr MAFB 
300  ng each 100  µl SD/glucose (–UL)
 
8 pSos MAFB + 
pMyr SB 
300  ng each 
 
100  µl 
 
SD/glucose (–UL)
 
9 pSos Bait 100  ng 100  µl SD/glucose (–L) 
 
10 pSos Bait + 
pMyr Lamin C 
300  ng each 
 
100  µl 
 
SD/glucose (–UL)
 
11 pSos Bait + 
pMyr SB 
300  ng each 
 
100  µl 
 
SD/glucose (–UL)
 
12  300  ng each  
100  µl 
 
SD/glucose (–L) 
 
Table 3.2.3: Transforming yeast and detecting protein-protein interactions 
 
growth at 37°C. Each picked colony was resuspended in 25 µl of sterile H2O and transferred to 
separate wells of sterile 96-well plate. 2.5µl of the yeast/ H2O suspensions was spotted onto 
each of two SD/galactose (–UL) agar plates and two SD/glucose (–UL) agar plates. One plate of 
each type was incubated at 37°C. The second plate of each type was kept at room temperature 
(22–25°C) for 5 days. Growth in SD/galactose (–UL) agar plates that are incubated at 37°C was 
scored after 7–10 days incubation.  
 
3.2.3.5 Library screening 
 
40µg of pSos bait construct, 40µg of pMyr cDNA plasmid library and 200 µl of 1.4M β-
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mercaptoethanol was added to 10ml of freshly prepared cdc25H (α) yeast competent cells. The 
contents were mixed thoroughly and the contents were transferred into 20 separate 
microcentrifuge tubes. Cotransformation was done as mentioned in the previous section. Cells 
were resuspended in 0.5 ml of 1 M sorbitol. The entire transformation reaction in each tube was 
plated on a 150-mm SD/glucose (–UL) agar plate. Plates were incubated at room temperature 
(22–25°C) for 2-4 days. The transformants were replica plated onto SD/galactose (–UL) agar 
plates and the plates were incubated at 37°C.  
After 6 days, colonies (interactor candidates) from the experimental library screen 
transformation replicates were picked on galactose incubated at 37°C. In order to repress GAL1 
promoter-driven expression from the pMyr library prior to interaction tests, cells from the 
interactor candidate colonies were patched onto an SD/glucose (–UL) agar plate (candidate patch 
plate), and the plate incubated at 22–25°C for 48 hours. The original galactose transformation 
replica plates were returned to 37°C after picking colonies, since some additional colonies 
appeared much later (10 days). 
After 48 hrs incubation, cells from the SD/glucose (–UL) candidate patch plates were patched 
onto two fresh SD/glucose (–UL) plates and one SD/galactose (–UL) plate. As a primary test to 
identify interactors among the candidates, one SD/glucose (–UL) and the SD/galactose (–UL) 
plate was incubated at 37°C for approximately 48 hours. The other SD/glucose (–UL) agar plate 
was kept at room temperature (22–25°C) as a re-patching source plate. 
After  the  48  hour  incubation, the  primary  interaction test plates  (see  step  16) were 
evaluated,  identifying  the  patches  growing  at  37°C  on SD/galactose  (–UL)  plates,  but  
not  on  SD/glucose  (–UL)  plates. A  secondary  interaction  test was performed by  re-
patching  the  interactor candidates from the re-patching source plate kept at 22–25°C onto 
another set of one SD/glucose (–UL) and one SD/galactose (–UL) agar plate, and both plates 
w e r e  i n c u b a t e d  at 37°C for 48 hours. The candidates producing patches that grow on 
SD/galactose (–UL) plates but not on SD/glucose (–UL) plates at 37°C in both the primary and 
secondary interaction tests should be considered “putative positive” clones and analysed further. 
 
3.2.3.6 Verification of interaction by yeast co transformation 
 
Putative positive colonies were grown in SD/glucose (–UL) media, cDNA library inserted 
plasmid ‘pMyr’ was isolated from this yeast culture by lysing yeast cells followed by 
phenol/chloroform extraction. Top aqueous phase containing the DNA was transferred to a  new 
microcentrifuge tube and DNA was precipitated with 100% (v/v) ice-cold ethanol at –20°C 
overnight or at –80°C for 15 minutes. Suspension was spun at 14,000 × g for 10 minutes at 4°C. 
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DNA pellet was washed with 70% (v/v) ethanol and centrifuged at 14,000 × g for 5 minutes at 
room temperature and the pellet was air dried,  resuspended in 40 µl of dH2O. 
DNA was precipitated with 3M NaOAc (pH 5.2) and ethanol. The above mentioned washing 
steps were repeated twice. DNA pellet was resuspended in 20 µl of dH2O followed by 
retransformation in high-efficiency electroporation-competent E. coli cells. Transformed 
colonies were selected for pMyr cDNA plasmid by plating on LB-chloramphenicol agar plates. 
Colonies that contain the pMyr cDNA plasmid w e r e  i d e n t i f i e d  by preparing miniprep. 
Isolated p l a s m i d  DNA was subjected to restriction digest analysis and the cDNA insert was 
identified by sequencing. 
 
3.2.4 Expression, purification and analysis of recombinant p86DM 
 
 
3.2.4.1 Expression His SUMO fused-p86DM protein 
 
p86DM was cloned into pET-SUMO expression vector and retransformed (as mentioned in 
previous section) in Rosetta competent cells. Transformed cell suspension was spread on LB 
agar plate and incubated at 37°C for 12-16h. Positive clone was picked and inoculated in LB 
broth followed with incubation at 37°C until the absorbance showed 0.5 at OD600. Grown 
culture was shifted to 27°C, expression of fusion protein was induced by adding 1mM IPTG at 
27°C for 210 min. The cells were pelleted by centrifugation at 3,000 g at 4°C for 10 min, 
supernatant was discarded. Cell pellet were resuspended in 3 ml ice-cold PBS buffer per 50 ml 
culture and centrifuged at 3,000 g at 4°C for 10 min and the pellets were frozen at -80°C for 1 hr. 
The cells were thawed on ice and re-suspend cells in 3 ml of ice-cold PBS buffer per 50 ml 
culture. Cells were broken by brief pulses of sonication on ice until the sample was no longer 
viscous. 10 μl aliquots sample from both soluble and insoluble fractions for SDS-PAGE analysis 
were taken (by adding equal volume of 5X SDS sample loading buffer, boil for 5 min and run 
SDS-PAGE to determine the amount and solubility of the fusion protein).  
 
3.2.4.2 Purification of recombinant His SUMO fused-p86DM protein  
An appropriate amount of High-Affinity His resin (50% slurry) was transferred to a disposable 
column using a pipette. (Usually 1 ml of resin can bind more than 6 mg of His protein). The resin 
was equilibrated with 10 bed volumes of cold lysis buffer. Clear solution (supernatant of the cells 
lysed by sonication) containing fusion protein was applied to the pre equilibrated column and 
with the flow rate at 5 ml/min. Column was washed with 20 bed volumes of washing buffer 
containing protease inhibitors. The fusion protein was eluted with 10-15 bed volumes of freshly 
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made elution buffer containing 250mM imidazole. 10-20 μl aliquots of flow through, wash and 
the eluted protein were analyzed by running SDS-PAGE to confirm the presence of the target 
protein. The eluted fractions were pooled and dialysed against TBS at 4°C to remove imidazole. 
 
3.2.4.3 SDS –Polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein  lysates  were  separated  on  a SDS-polyacrylamide  gel  prepared  according  to  the 
compositions mentioned in table 3.1. 
Preparation of stacking gel (for 2 /10 gels 10/50 ml) 
Maxi gels Mini gels 
Ingredients 
Stacking Separating Stacking Separating 
30% Acrylamide 1.6 ml (4%) 22.2 ml 440 µl 3.3 ml 
Lower Tris --- 16.7 ml --- 2.5 ml 
Upper Tris 3 ml --- 1.0 µl --- 
Water 7.4  ml 27.8  ml 2.6 ml 4.2 ml 
Temed 20 µl 67 µl 6 µl 10 µl 
10 % APS 100 µl 70 µl 40 µl 100 µl 
Table 3.2.4: Composition of SDS polyacrylamide gels 
 
The protein samples were denatured at 98°C for 5 min, centrifuged briefly and allowed to cool to 
room temperature.  Depending on the molecular weight of the protein analysed, the samples were 
loaded onto SDS-PAGE of 8% or 10% gels, in an apparatus containing running buffer in both 
chambers. A constant voltage of 40 V was applied per gel until the loading dye (bromophenol 
blue) entered the separating gel. Then the voltage was increased to 80 V until the dye reached the 
bottom of the gel. The proteins were then blotted onto PVDF membranes. 
 
3.2.4.4 Western Blotting 
PVDF membrane was activated in methanol for 1 min and then equilibrated for 10 min in 1x 
Towbin buffer. The SDS-polyacrylamide gel was dismantled from the electrophoresis equipment 
and the stacking gel was excised.  The separating gel was equilibrated in 1x Towbin buffer for 10 
min and set up for semi-dry blotting as per manufacturers’ directions. Protein transfer was 
achieved at a constant current of 1.0 mA/cm2 of membrane. After blotting, the membrane was 
stained with Coomaasie G250 stain and destained with destaining solution. The marker was re-
marked using a pencil and the membrane was scanned for future reference.  
For Western blotting, the membrane was washed with TBST buffer. Non specific binding sites 
were blocked by incubating the membrane with either 5% skimmed milk powder or 5% BSA in 
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TBS containing 0.1% tween-20 (TBS-T) for 1h. After blocking, the membrane was incubated 
with primary antibody diluted in blocking solution for 1 hour at RT or o/n at 4°C and washed 
thrice with TBS-T for 5 min each at RT, to remove any unbound antibodies.  The membrane was 
then incubated with corresponding secondary antibody, diluted in blocking solution for 1 hour at 
RT and washed thrice with TBS-T for 5 min each at RT. A final wash was carried out with 1x 
TBS, pH 7.5. Bound antibodies were visualised with ECL system (Amersham Pharmacia) 
according to the manufacturer’s protocol or with indigenous ECL system. 
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4. Results 
 
4.1 Screening of keratin associated proteins by yeast two hybrid system 
4.1.1 Target cDNA library construction 
 
In order to construct a cDNA library to identify the K5 and K14 associated proteins, total RNA 
was isolated from human skin sample (kindly provided by Prof. Bruckner-Tuderman, Freiburg) 
and 500,000 cDNA fragments were prepared using random primers. The average size of the 
fragments measured 1.2 kb ranging from the smallest fragment 500 bp to 4 kb, which were 
subsequently inserted into pMyr expression vector as Myr-target fusions. 
Multiple cloning site of the pMyr expression vector was modified by inserting SalI and NotI 
restriction sites at 5` and 3´ ends respectively, to facilitate the insertion of the cDNA fragments.  
 
Figure 4.1: Size range from 500bp – 4kb of inserted cDNA fragments in the target cDNA library  
 
cDNA fragments from purified total RNA were inserted into the modified pMyr by RZPD 
GmbH. Berlin. This cDNA library was used in the screening experiments for identifying K5 and 
K14 associated proteins.    
 
4.1.2 Bait plasmid construction 
 
Head, rod and tail domains of K5 and K14 were used as baits to identify their interacting partners 
using Sos recruitment method.  
DNA encoding the head, rod and tail domains of K5 and K14 protein were prepared from the full 
length cDNA by PCR amplification using specific primers. PCR amplified product was cloned 
into the cloning vector, plasmid DNA was isolated by miniprep, specificity of the PCR amplified 
product was confirmed by sequencing. DNA coding for the respective domain was obtained by
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digesting the cloning vector containing desired insert with the restriction enzymes, purified by 
gel extraction and ligated into the pSos expression plasmid as gene fusion with hSos protein.   
Insertion sites 
 Bait domain 
Insert 
length 5´ 3´ 
Position in pSos 
expression vector 
1 
Keratin5 head 
(K5Hd) 
510 bp BamHI SalI 3223 - 3733 
2 
Keratin5 rod 
(K5Rd) 
929 bp BamHI NotI 3223 - 4512 
3 
Keratin5 tail 
(K5Td) 
343 bp BamHI NotI 3223 - 3566 
4 
Keratin14 head 
(K14Hd) 
363 bp BamHI SalI 3223 - 3586 
5 
Keratin14 rod 
(K14Rd) 
932 bp BamHI NotI 3223 - 4155 
6 
Keratin14 tail 
(K14Td) 
149 bp BamHI NotI 3223 - 3372 
 
Table 4.1: Cloning details of the bait inserts as fusion with hSos gene in pSos expression vector. 
 
The pSos vector contains DNA encoding amino acids (aa) 1 to 1067 of the hSos gene and unique 
3´ cloning sites with ADH1 promoter for the expression of the hSos-bait insert fusion.  
It contains the pUC and 2μ origins for replication in E. coli and yeast, respectively. The pSos 
also carry yeast biosynthetic genes LEU2 for selection of yeast transformants based on 
nutritional requirements. The pSos vector contains the ampicillin-resistance gene which enables 
for the selection while recovering plasmids from E. coli. Details of the cloned bait plasmids is 
listed in the above table No.4.1 
 
4.1.3 Verification of yeast host strain marker phenotype 
 
In the present study yeast strain cdc25H (α), genotype: ‘MATα ura3-52 his3-200 ade2-101 lys2-
801 trp1-901 leu2-3 112 cdc25-2 Gal+’ was used. The phenotype of the yeast host strain was 
verified prior to competent cell preparation for the subsequent experiments. Cells were obtained 
from the glycerol stock and were grown at 24°C on SD agar plates lacking the nutrients 
tryptophan (Trp), leucine (Leu), histidine (His), and uracil (Ura). The plates were incubated for 6 
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days at 24°C. Simultaneously another culture from the same stock was inoculated on YPAD agar 
plate and incubated at 24°C or 6 days.  
 
Growth media Growth 
SD agar(-Trp) – 
SD agar(-Leu) – 
SD agar(-His) – 
SD agar(-Ura) – 
YPAD agar + 
 
Table 4.2: Verification of yeast host strain marker phenotype by testing for growth using dropout media.  
 
Growth on YPAD agar plate and absence of growth on any of the four SD agar dropout plates as 
indicated in the table confirmed the phenotype of the yeast strain.  
The yeast colonies from the YPAD agar plates were used for preparing the competent cells.  
 
4.1.4 Confirmation for absence of temperature revertants 
 
The screening procedure is based on the selection of temperature sensitive growth of the yeast 
colonies for the detection of positive keratin interacting partners. So it is of utmost importance to 
check for the absence of temperature revertants in the prepared competent cells to avoid false 
positives in the process of screening for keratin associated proteins. 
Competent cells of cdc25H(α) were prepared from the phenotype verified yeast colonies, and 
cotransformed with the set of negative control plasmids  pSos MAFB and pMyr Lamin C as 
described in methods. The cotransformed cells were plated on SD/glucose (–UL) dropout agar 
plate and incubated at 37°C for 6 days.   
The incubated plate was observed daily for 6 days. No colonies were observed till 6th day of 
incubation at 37°C. This confirms that there were no temperature revertant CFUs present in the 
stock of yeast competent cells used for detection of keratin interacting partners.  
 
4.1.5 Control plasmids 
 
For validation of screening process, different sets of control plasmids have been used. These 
were cotransformed as control groups along with test groups which were used for the 
identification of positively interacting candidates. 
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The different combinations of control plasmids mentioned in section 3 were cotransformed in 
competent cells of cdc25H(α). Cotransformation was done in duplicate sets, first set of 
transformed mixture was spread on SD-glucose(-U,L) agar plates and incubated at 24°C for 4-6 
days till the colonies were visible. The other set of transformed mixture was spread on agar 
plates containing SD-galactose(-U,L) and the plates were incubated at restrictive temperature 
37°C for 6 days and observed daily for growth. The growth profile of the transformed colonies is 
tabulated below in table No: 4.3  
 
Combination of control  
plasmids cotransformed 
SD (–UL)/24°C SD (–UL)/37°C 
Sos fusion Myr fusion Glucose Galactose Glucose Galactose 
MAFB MAFB + + – + 
Cadherin Armadillo + + – + 
MAFB SB + + – + 
MAFB Lamin C + + – – 
Col I MAFB + + – – 
Table 4.3: Growth profile of the cdc25H(α) yeast cells cotransformed with control plasmids.  
Growth was observed in both sets of transformation which were spread on the agar plates 
containing SD-glucose(-U,L)/SD-galactose(-U,L), incubated at 24°C. Agar plates with SD-
galactose(-U,L) containing yeast cells cotransformed with positive control plasmids were able to 
grow when incubated at restrictive temperature 37°C, where as the plates containing yeast 
cotransformed with negative control plasmids failed to grow at restrictive temperature.  
These results validate the system to be used for the screening studies of keratin associated 
proteins.  
 
4.1.6 Verification of bait plasmid suitability for screening assays  
 
The constructed bait plasmids (pSos-bait) were verified for their compatibility with the system in 
order to avoid false positives arising from them. 
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4.1.6.1 Verification for auto-activation  
 
The fusion of bait sometimes results in self-activation of the signal recruitment system. 
Therefore, it is essential to test each bait for its inability to confer growth of cdc25H at the 
restrictive temperature. Prior to initiating the yeast two-hybrid screen using the constructed pSos 
bait plasmids, it was verified that the pSos-bait fusion does not interact with the myristylation 
signal in the absence of an interaction partner. The individual pSos bait plasmids (containing the 
genes of head, rod and tail domains of K5 and K14) were cotransformed into the yeast host with 
either pMyr empty vector or pMyr Lamin C to establish that the bait protein does not interact 
with the myristylation signal provided by the negative control plasmids. Co-transformation was 
performed according to the protocols outlined in Methods. After cotransformation, the plates 
containing glucose were initially incubated at room temperature (24°C) to allow colony 
formation. Colonies which were grown on these plates were patched onto fresh plates containing 
galactose, and assayed for growth at 37°C.  
If the bait plasmid cotransformed with the pMyr empty vector or pMyr Lamin C can induce 
cdc25H yeast growth at 37°C, then the bait plasmid is unsuitable for detecting protein-protein 
interactions in the CytoTrap system. Induction of growth of the yeast host at 37°C by the bait 
plasmid may also occur if the bait protein contains sequences that target them to the membrane. 
In the figure: 4.2/4.3 a, b and c, absence of growth of yeast colonies at 37°C cotransformed with 
the above mentioned pSos bait constructs and pMyr Lamin C indicates that there is no auto 
activation as  bait proteins do not  interact with the myristylation signal from the negative control 
plasmid and hence are suitable for the screening experiments.      
 
Figure 4.2: No growth confirms suitability of the K5 bait constructs for two hybrid screening 
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 a) pSos-K5Hd, b) pSos-K5Rd, c) pSos-K5Td, and pMyr Lamin C were cotransformed in cdc25 H yeast strain, 
plates containing glucose (-Leu/-Ura) were  initially incubated  at   room   temperature (24°C) for 4 days to allow 
colony formation. Three individual colonies grown at p e r mi s s ive  temperature were selected and spotted 
onto fresh plates containing galactose(-Leu/-Ura), and assayed for growth at restrictive temperature (37°C) for 6 
days to check if the bait plasmid cotransformed with the pMyr Lamin C can induce cdc25H yeast growth at 
37°C. 
 
Bait plasmids constructed using PCR amplified product of head, rod and tail domain encoding 
DNA of K5 was inserted in pSos vector, expressing as fusion protein with Sos protein. 300ng of 
each of the bait plasmid along with 300ng of pMyr Lamin C were cotransformed in 100µl of 
competent cdc25H(α) cells previously tested for absence of temperature revertion. Growth was 
observed after 4 days of incubation at permissive temperature on agar plates containing SD-
glucose(-U,L). Three of the grown colonies were picked randomly, resuspended in 20µl of sigma 
water and spotted on agar plates containing SD-galactose(-U,L). Plates were inverted and 
incubated at restrictive temperature and were observed daily for 6 days.  
No growth was observed till 6 days of incubation at 37°C indicating that, the bait plasmids 
constructed with different domains of K5 do not possess self-activation property and are suitable 
for the screening assay. 
 
 
Figure 4.3:  No growth confirms the suitability of K14 bait constructs for two hybrid screening 
 
a) pSos-K14Hd, b) pSos-K14Rd, c) pSos-K14Td, and pMyr Lamin C were cotransformed in cdc25 H yeast strain, 
plates containing glucose (-Leu/-Ura) were  initially incubated  at   room   temperature (24°C) for 4 days to allow 
colony formation. Three individual colonies grown at p e r mi s s ive  temperature were selected and spotted 
onto fresh plates containing galactose(-Leu/-Ura), and assayed for growth at restrictive temperature (37°C) for 6 
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days to check if the bait plasmid cotransformed with the pMyr Lamin C can induce cdc25H yeast growth at 
37°C. 
 
Bait plasmids constructed comprising head, rod and tail domains of K14 were cotransformed 
along with pMyr Lamin C (300ng each) in 100µl of competent cdc25H(α) cells previously tested 
for absence of temperature revertion. Absence of growth on SD- galactose(-U,L) plates 
incubated at 37°C was evaluated similar to that of previous results of K5 domain expressing bait 
constructs. Absence of growth indicated that, the bait plasmids constructed with different 
domains of K14 do not possess self-activation property and are suitable for the screening assay. 
 
4.1.6.2 Verifying bait insert cloning and expression 
 
The nucleotide sequence of the cloning junctions between pSos and DNA insert encoding for 
bait protein was determined by sequencing the column purified plasmid DNA. Which in turn 
also confirmed that the bait protein will be expressed in frame with the Sos domain and the DNA 
insert does not contain mutations.  
Expression of the bait protein can be verified by either  
a) Western blot analysis using an antibody that immunoreacts either with the protein 
expressed from the DNA insert or with the hSos protein  
b) The cytoplasmic localization of the bait protein can be verified by cotransformation 
of pMyr SB and the pSos bait plasmid followed by patching on galactose containing 
medium and assaying for growth at 37°C. 
In the present set of studies verification of expression of the DNA encoding bait proteins as 
fusion protein along with Sos protein was confirmed by the genetic interaction of the expressed 
Sos protein with the SB protein, which is expressed from pMyr SB to rescue the growth at 
restrictive temperature 37°C that confirms the integrity and cytoplasmic localization of the pSos 
vector. 
 
Expression and cytoplasmic localization of K5 and K14 domains in frame with Sos protein 
The cytoplasmic localization of the head, rod and tail domains of K5 bait protein was verified by 
cotransforming the pSos-K5 bait constructs with pMyr SB followed by patching on galactose 
containing dropout medium and assayed for growth at 37°C. 
Ability of the cotransformed colonies (figure 4.4) confirms that bait proteins pSos-K5Hd, pSos-
K5Rd and pSos-K5Td are intact and their cytoplasmic localization.  
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Expression and cytoplasmic localization of K14 bait constructs pSos-K14Hd, pSos-K14Rd and 
pSos-K14Td was also confirmed in the similar set of experiments. 
Ability for the growth of cotransformed yeast cells with pSos-K14bait and pMyr SB at restrictive 
temperature 37°C on galactose containing dropout media (figure 4.5) confirms the integrity and 
cytoplasmic localization of K14 bait fusion proteins. 
Expression and cytoplasmic localization of K5 head, rod and tail domains   
 
Figure 4.4: Growth of cotransformed yeast colonies confirms the integrity & expression of Sos-K5 head, rod 
and tail domains in cdc-25H 
a) pSos-K5Hd, b) pSos-K5Rd, c) pSos-K5Td, and pMyr SB were cotransformed in cdc25 H yeast strain, plates 
containing glucose (-Leu/-Ura) were  initially incubated  at   room   temperature (24°C) for 4 days to allow colony 
formation. Selected individual colonies grown at p e rmi s s iv e  temperature were selected and spotted onto 
fresh plates containing galactose(-Leu/-Ura), and assayed for growth at restrictive temperature (37°C) for 6 days to 
check if the bait plasmid cotransformed with the pMyr SB can induce cdc25H yeast growth at 37°C. 
Expression and cytoplasmic localization of K14 head, rod and tail domains   
 
Figure 4.5: Growth of cotransformed yeast colonies confirms the integrity & expression of Sos-K14 head, rod 
and tail domains in cdc-25H 
a) pSos-K14Hd, b) pSos-K14Rd, c) pSos-K14Td, and pMyr SB were cotransformed in cdc25 H yeast strain, plates 
containing glucose (-Leu/-Ura) were  initially incubated  at   room   temperature (24°C) for 4 days to allow colony 
formation. Selected individual colonies grown at p e rmi s s iv e  temperature were selected and spotted onto 
fresh plates containing galactose(-Leu/-Ura), and assayed for growth at restrictive temperature (37°C) for 6 days to 
check if the bait plasmid cotransformed with the pMyr SB can induce cdc25H yeast growth at 37°C. 
 
4.1.7 Detection of keratin associated proteins by cotransformation of K5/ K14 bait plasmids 
and target cDNA library 
 
Screening for the identification of novel keratin associated proteins was performed by 
introducing the keratin bait and target cDNA containing plasmids into the cdc25H(α) yeast strain 
by cotransformation.  This strategy of cotransformation allows results to be generated faster than 
mating technique as the latter method limits the number of generations of growth prior to the 
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interaction assay, and thus reduces the incidence of cdc25H reversion leading to false positives. 
Cotransformation is especially useful if the bait plasmid is toxic to the yeast cells.  
SD (–UL)/37°C 
 Number 
 
Plasmids 
Transformed 
 
SD Glucose    
(–UL) /24°C Glucose Galactose 
1 pSos  + pMyr + 
 
NA 
 
– 
 
2 pSos MAFB + 
pMyr MAFB 
+ 
 
– 
 
+* 
 
3 pSos MAFB + 
pMyr SB  
+ 
 
– 
 
+* 
 
4 pSos Col I + 
pMyr MAFB 
+ 
 
– 
 
–* 
 
5 pSos MAFB + 
pMyr Lamin C 
+ 
 
– 
 
– 
 
6 pSos K5Hd + 
pMyr cDNA lib 
+ 
 
– 
 
+ 
 
7 pSos K5Rd + 
pMyr cDNA lib 
+ 
 
– 
 
+ 
 
8 pSos K5Td + 
Myr cDNA lib 
+ 
 
– 
 
+ 
 
9 pSos K14Hd + 
pMyr cDNA lib 
+ 
 
– 
 
+ 
 
10 pSos K14Rd + 
pMyr cDNA lib 
+ 
 
– 
 
+ 
 
11 pSos K14Td + 
pMyr cDNA lib + 
– + 
Table 4.4:  Combination of the plasmids cotransformed and the growth profile of the transformed cdc25H(α) 
yeast cells. 
 Group 1 is used for verification of temperature revertants and to calculate cotransformation efficiency. Groups 2-5 
served as positive and negative contols. Groups 6-11 represent the test groups for identification of positively 
interacting protein partners from cDNA library. * Colonies grown at 24°C on SD glucose containing plates were 
picked randomly and spotted on galactose containing plates followed with incubation at growth restrictive 
temperature 37°C. 
 
Cotrasformation of competent cdc25H(α) yeast cells was performed as detailed in the methods 
section. Growth profile of the transformed yeast colonies is outlined in table No. 4.4. The first 
group with empty pSos and pMyr plasmids was used to test for the temperature revertants and to 
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calculate the cotransformation efficiency. Second and third group served as positive controls 
(figure 4.5), fourth and fifth group of cotransformation were used as negative control (figure 4.6) 
for the experiment. 
Initially, the pMyr cDNA library and pSos bait cotransformant colonies are selected at 
permissive temperature 24°C on glucose containing SD droupout media. Candidate interactors 
are identified by replica plating the cotransformants to 37°C. “Putative positives” are identified 
among the candidates by two rounds of testing for galactose dependent growth at 37°C.  
The putative positives colonies obtained after the initial screening were picked individually and 
inoculated in glucose containing SD broth, incubated for four days at 24°C with shaking.  
Yeast DNA was isolated from the grown cultures and was retransformed into XL1 blue E.coli by 
electrotransformation. Transformed bacterial cells were spread on LB agar plates containing 
chloramphenicol for the selection of the bacterial cells containing cDNA fragments inserted 
pMyr plasmid. Column purified plasmid DNA containing putative interacting fragments from the 
cDNA library was isolated by miniprep. Each of the isolated samples were subjected to 
restriction with Sal I and Not I restriction enzymes to check for the size of inserted fragment. As 
mentioned in the previous section the minimum size of the inserted DNA fragment in the pMyr 
cDNA library was about 500bp, so only the fragments which were more than 500bp were 
selected for the further analysis. The number of putative positive candidates obtained by 
screening of individual bait is tabulated in table No. 4.5. 
 
4.1.7.1   Cotransformation of pSos MAFB – pMyr MAFB (positive control) and pSos Col I 
– pMyr MAFB (negative control) 
 
 
Figure 4.6: Positive and negative controls for yeast two hybrid screening 
a) pSos and pMyr plasmids encoding for MAFB protein were cotrasformed in cdc25H yeast strain and plated on 
tbe agar plates containing glucose(-Leu/-Ura), incubated at growth permissive temperature (24°C) for 3-4 days. 
Individual colonies were selected and spotted onto agar plates containing galactose(-Leu/-Ura). The plates were 
incubated at restrictive temperature (37°C) for 4-6 days. 
b) pSos and pMyr plasmids encoding for Col I, MAFB proteins respectively were cotrasformed in cdc25H yeast 
strain and plated on tbe agar plates containing glucose(-Leu/-Ura), incubated at growth permissive temperature 
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(24°C) for 3-4 days. Individual colonies were selected and spotted onto agar plates containing galactose(-Leu/-
Ura). The plates were incubated at restrictive temperature (37°C) for 4-6 days. 
 
Cotransformation of pSos MAFB – pMyr Lamin C (negative control) 
 
 
Figure 4.7: Negative control for yeast two hybrid screening 
 
a)   pSos and pMyr plasmids encoding for MAFB, laminC proteins respectively were cotrasformed in cdc25H yeast 
strain and plated on the agar plates containing glucose(-Leu/-Ura), incubated at growth permissive temperature 
(24°C) for 3-4 days.  
b)  The colonies which appeared at permissive temperature were replica plated onto agar plates containing 
galactose(-Leu/-Ura), incubated at growth restrictive temperature (37°C) for 6 days. 
 
The transformation mixture from group 1 (table No. 4.4) was used to check for the temperature 
revertants and to calculate cotranformation efficiency. 390µl of the transformed mixture was 
spread on SD glactose (-U, L) agar plates and incubated at 37°C. The plates were observed daily 
for 6 days to check for growth. No growth was observed indicating the competent cells used for 
screening experiments were void of temperature revertants. 110µl from the same transformation 
mixture was spread on SD glucose (-U, L) agar plate and incubated at 24°C for four days to 
evaluate the transformation efficiency of the competent cells used for screening experiment.  
Cotransformation efficiency was found to be 4.3 x 103 cfu/μg of plasmid DNA used which was 
in the standard range of 0.5 x 103 to 1 x 104 cfu/ μg DNA. 
The transformation mixture of test groups cotransformed with keratin bait plasmids and target 
cDNA library containing plasmids were spread on SDglucose (-U, L) agar plates (20 numbers) 
and incubated at room temperature for four days. The colonies grown were transferred on to 
galactose containing media followed with the incubation at 37°C for 6 days.  
The image below (figure 4.8) demonstrates the robustness of the selection system based on the 
growth of yeast colonies harboring putative positive interaction at restrictive temperature.  
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 Figure 4.8: Selection of temperature sensitive cotransformed yeast colonies  
pSos-K5Hd and pMyr-cDNA library containing plasmids were cotransformed in to cdc25H(α), spread on 
SDglucose(-U, L) agar plate and incubated for 4 days at 24°C. Approximately 3500 colonies appeared, which were 
subsequently replica plated on to galactose containing media followed with incubation at restrictive temperature 
37°C. Only 8 colonies appeared at restrictive temperature which represents putative positive interacting candidates 
for keratin 5 head domain. 
 
All the colonies which appeared on galactose containing plates incubated at 37°C, were picked 
individually and grown in liquid broth for four days. Yeast DNA was isolated from the grown 
cultures and retransformed into E.coli followed by chloramphenicol selection to isolate pMyr 
plasmid containing cDNA insert. Column purified plasmid DNA from E.coli was analyzed for 
the insert size by double digesting with Sal I and Not I restriction enzymes. In total 2475 putative 
positive candidates were identified as K5 and K14 associated proteins. The below table outlines 
the number of putative positive candidates obtained for each of the K5 and K14 domain used as 
bait to identify their interaction partners. 
 
4.1.8 Identification of positive candidates from screening 
 
DNA fragment contained in pMyr plasmid was identified by sequencing the insert using specific 
primers for the pMyr plasmid. 100 random samples for K5 and K14 associated candidates whose 
insert size was more than 500 bp were sequenced. Obtained sequence data was analyzed using 
BLAST bioinformatics tool to identify the interacting protein.  
Only the results which covered more than 75% of query length and above 90% sequence identity 
were considered (Figure: 4.9). The interesting candidates were confirmed for its interaction with 
their respective keratin domains by cotransforming the specific bait and isolated pMyr plasmids 
in cdc25H(α) assaying for the growth at restrictive temperature 37°C. 
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Sl.No Keratin bait 
 domain 
Number of positively 
interacting candidates 
isolated 
1 Keratin 5 head 434 
2 Keratin 5 rod 535 
3 Keratin 5 tail 240 
4 Keratin 14 head 460 
5 Keratin 14 rod 486 
6 Keratin 14 tail 320 
 
Table 4.5 : Number of positive interacting candidates isolated using head, rod and tail domains of K5 / K14 as 
bait against skin cDNA library by ‘Sos recruitment’ yeast two hybrid  genetic screening technique.  
 
Rod domains of keratins are responsible for formation of the keratin heterodimers with the other 
type of keratins. To evaluate if the candidates obtained by using rod domains as bait contained 
any keratins, Southern blotting was done using contemporary keratin rod domains as probes. For 
the candidates isolated with K5 rod as bait, K14 rod was used as probe and for the one identified 
as K14 rod interacting partners were tested against probe prepared from K5 rod domain.  
Among 535 candidates identified with K5 rod domain as bait, seven of them were found to type I 
keratins. 5 out of 460 candidates obtained as K14 rod interacting partners turned out to be type II 
keratins.   
 - 60 -
  Results                
 
 
Figure 4.9: An example of BLAST report  
Query submitted from results obtained from sequencing the putative positive candidates identified as keratin 
associated proteins using Sos recruitment system.  
 
The keratin associated proteins identified from BLAST analysis contained well characterized, 
known proteins to unannotated and hypothetical ones which are yet be investigated for their 
functions and properties. Few of the candidates from the 200 sequenced results are mentioned in 
table No. 4.6 and 4.7   
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Positive interacting protein partners of K5  
 
 
Number 
 
Name identified by BLAST analysis 
1 Homo sapiens Annexin 2 
2 Bromodomain and PHD finger containing 3, (BRPF3) 
3 Calmodulin-like skin protein (CLSP), the CALML3 gene for calmodulin-like 3 (CLP) and four CpG islands 
4 Homo sapians calmodulin-like 5 (CALML5) 
5 Homo sapiens Crm, cramped-like (Drosophila) (CRAMP1L) 
6 Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 (DDX17) 
7 Homo sapiens eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) 
8 Homo sapiens glycine amidinotransferase (L-arginine:glycine amidinotransferase) (GATM) 
9 Homo sapiens isocitrate dehydrogenase 3 (NAD+) beta (IDH3B) 
10 Homo sapiens LY6/PLAUR domain containing 3 (LYPD3), (C4.4A) 
11 Homo sapiens peroxiredoxin 5 (PRDX5) 
12 Homo sapiens TAP binding protein (tapasin) (TAPBP) 
13 Homo sapiens TBC1 domain family, member 10A (TBC1D10A) 
14 Homo sapiens transmembrane anterior posterior transformation 1 (TAPT1) 
15 Homo sapiens unc-84 homolog B (C.elegans) 
16 Homo sapiens WD repeat domain 71 (WDR71) 
17 Homo sapiens WW domain binding protein 1 (WBP1) 
18 Homo sapiens zinc finger, NFX1-type containing 1 (ZNFX1) 
19 Hypothetical protein LOC201895 
20 Hypothetical protein LOC283377 
 
Table 4.6: List of positive interacting candidates with K5 (alphabetical order) 
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Positive interacting protein partners of K14 
 
 
Number 
 
Name identified by BLAST analysis 
1 Calmodulin-like skin protein variant (CALML5) 
2 Homo sapiens calponin 3, acidic (CNN3) 
3 Homo sapiens calreticulin 
4 Homo sapiens CD74 antigen 
5 Homo sapiens chromodomain helicase DANN binding protein 3 (CHD3) 
6 Homo sapiens coiled-coil domain containing 72 (CCDC72) 
7 Homo sapiens cysteine-rich protein 2 
8 Homo sapiens Fibulin 2 
9 Homo sapiens immunoglobulin (CD79A) binding protein 1 (IGBP1) 
10 Homo sapiens mitogen-activated protein kinase kinase kinase kinase 2 
11 Homo sapiens RAB34 
12 Homo sapiens signal transducer and activator of transcription 6, (STAT6) 
13 Homo sapiens transcription factor AP-2 beta (TFAP2B) 
14 Homo sapiens tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, Theta polypeptide (14-3-3) 
15 Homo sapiens unc-84 homolog B (C. elegans) 
16 Homo sapiens zinc finger and BTB domain containing 4 (ZBTB4) 
17 hypothetical protein LOC727957 isoform 1 
18 p86DM 
19 Rho guanine nucleotide exchange factor (GEF) 19 
20 Uridine monophosphate kinase (UMPK protein) 
 
Table 4.7: List of positive interacting candidates with K14 (alphabetical order) 
 
 
 
 - 63 -
  Results                
4.2 Verification of the positive interacting candidates in mammalian cell culture system 
 
Transcription factor AP2β, Rab34 a small GTPase of the ras superfamily, 14-3-3τ a member of 
14-3-3 family proteins and the unannotated protein p86DM which were identified as K14 head 
domain interacting proteins by Sos recruitment technique were selected for further investigation 
to confirm their interaction with K14 in mammalian cell culture system.  
Even though the above mentioned proteins were identified as interacting partners of K14 head 
domain, owing to the stability and expression pattern of K14 head domain in the cell culture 
system, full length K14 was used to verify the interaction with the identified candidate proteins.  
To confirm the interaction, firstly expression of K14 head domain as GST fusion protein and 
subsequent efforts to perform pulldown assays of endogenously expressed candidates was not 
successful because of the aggregation of GST fusion protein. Similar kind of challenge was 
experienced when tried to express K14 head domain alone in mammalian cells.  
To overcome these challenges, full length K14 was used to confirm the interaction by 
‘Bimolecular fluorescence complementation technique’, which enables direct visualization of 
protein complexes in living cells and investigation of interactions in normal physiological cell 
environment.  
Full length keratin protein was expressed along with ‘N’ terminal half of Venus-YFP and 
candidate proteins were expressed in fusion with ‘C’ terminal half Venus-YFP. Direct interaction 
of the expressed K14 and candidate protein, constituted full length active Venus-YFP.    
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4.2.1 Positive control for BiFC studies V1–Flag–p0071 WT and V2–HA–RhoA WT 
The interaction of armadillo protein p0071 with RhoA a member of Rho-family of GTPases was 
reported by Wolf et al., 2006 using BiFC technique. So for the present study Venus tagged 
proteins of p0071 and RhoA were used as positive controls, which exhibited similar kind of 
fluorescence pattern as reported by authors (figure 4.10).  
 
Figure 4.10: Transfection of Venus plasmids used as positive control for BiFC experiments  
 
Association was determined by co-transfecting p0071-arm repeats fused to a Flag-tagged C-terminal YFP–Venus 
fragment (V1–Flag–p0071 WT) and the indicated Rho variants fused to the corresponding N-terminal part of YFP–
Venus with a HA-tag (V2–HA–RhoA WT) (kind gift by Prof. Hatzfeld, Halle; Wolf et al., 2006). The green signal 
represents YFP autofluorescence.  
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a & a` : MCF7 cells were transiently cotransfected with V1–Flag–p0071 WT and V2–HA–RhoA WT, and were 
fixed using PFA after 48 hours of transfection. p0071 associates with wild-type RhoA at the midbody as shown by 
the authors and served as a positive control for BiFC experiments carried out in the present study.  
b & b` : MCF7 cells were transiently transfected with V1–Flag–p0071 WT and were fixed using PFA after 48 hours 
of transfection. Absence of the green signal for YFP indicates there is no false or nonspecific signal from the YFP-
Venus1 fragment.  
c & c` : MCF7 cells were transiently transfected with V2–HA–RhoA WT and were fixed using PFA after 48 hours 
of transfection. Absence of the green signal for YFP indicates there is no false or nonspecific signal from the YFP-
Venus2 fragment. 
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4.2.2 Confirmation of interaction between K14 and AP2β by BiFC 
 
Interaction of K14 with AP2β a transcription activator was identified for the first time in yeast 
two hybrid screening studies. To check and confirm the relevance of this interaction in cultured 
mammalian cells, full length Venus tagged proteins of K14 and AP2β were expressed by 
cotransfecting in MCF-7 mammary epithelial cells.  
Different combinations of the expression plasmids (Table No. 4.8) were transfected in the 
experiment in order to control and to avoid any false positive fluorescence.   
Results of the positive control transfections are shown in next section of results. 
 
Sl.No Plasmid(s) transfected Group Fluorescence
1 K14-pVen1flag + AP2β-pVen2 HA Test + 
2 K14-pVen1flag Control - 
3 AP2β-pVen2 HA Control - 
4 K14-pVen1flag + pVen2 HA Control - 
5 pVen1flag + AP2β-pVen2 HA Control - 
Table 4.8: Different transfection groups used in experiment to confirm direct interaction of K14 with AP2β 
 
Full length K14 cDNA (1.73kb) was cloned in frame with amino terminal half of Venus-YFP 
(first 480bp from total 747bp of Venus-YFP). Flag tag was used to link carboxy end of Venus-
YFP fragment with amino terminal end of keratin14 and also to facilitate folding of Venus-YFP 
fragment.  
Full length AP2β cDNA (1.35kb) was cloned in frame with carboxy terminal half of Venus-YFP 
(last 267bp from total 747bp of Venus-YFP). HA tag was used to link carboxy end of Venus-
YFP fragment with amino terminal end of AP2β which also helps in proper folding of Venus-
YFP fragment to reconstitute full length active Venus-YFP.  
 
 
Figure 4.11:  Schematic representation of the Venus-YFP constructs. 
 
 
 - 67 -
  Results                
4.2.2.1 Cotransformation of full length cDNA inserted K14-pVen1flag and AP2β-pVen2 
HA plasmids 
 
In order to confirm the interaction of K14 and AP2β in mammalian cell culture system, Venus 
expression plasmids inserted with full length K14 and AP2β cDNA were cotransfected into 
MCF-7 cells. As a result of the direct interaction between the expressed proteins, Venus-YFP 
activity is reconstituted and led to accumulation of autofluorescence at the site of intracellular 
interaction (figure 4.12). A strong direct interaction was observed upon maturation of the YFP 
fluorescence along the expressed K14 filaments in the cytoplasm of transfected cells. 
Cotransformation efficiency of more than 40% was seen in all repetitive trials conducted to 
confirm the result. 
The autofluorescence emitted by the reconstitution of active Venus-YFP when cotransfected in 
MCF-7 cells strongly suggests that K14 binds to AP2β and sequesters in cytoplasm of the cells. 
 
 
  
Figure 4.12: BiFC analysis of transiently transfected MCF7 cells with AP2β and K14 Venus constructs. 
MCF7 cells were cotransfected with K14-Venus1Flag-N and AP2β-Venus2HA-C. Cells were fixed and analyzed 
after 48 hours of transfection. The green signal represents the YFP autofluorescence as a result of the formation of 
active YFP from the complementing halves due to the direct interaction between K14 and AP2β which are fused 
with the corresponding Venus halves. Distribution resembles to characteristic expression of endogenous keratin 
cytoskeleton.  Scale bar 10 μm 
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4.2.2.2 Individual transformation of full length cDNA inserted K14-pVen1flag and AP2β-
pVen2 HA plasmids 
 
Venus expression plasmids inserted with full length K14 and AP2β were transfected individually 
into MCF-7 cells to check for emittance of false fluorescence signal from the individual Venus-
YFP fragments. The results indicated that upon transfection of AP2β-pVen2 HA and K14-
pVen1flag, there was no non specific fluorescence emitted from the individual Venus-YFP 
fragments (figure 4.13). Transfection efficiency with eYFP plasmid ranged between 55 to 65 %. 
 
 
Figure 4.13: BiFC analysis of transiently transfected MCF7 cells with AP2β and K14 Venus constructs. 
a & a` : MCF7 cells transiently transfected with AP2β-Venus2HA-C and analyzed after 48 hours of transfection. 
Absence of the green signal for YFP indicates there is no nonspecific signal from the YFP-Venus2 fragment. 
b & b` : MCF7 cells transiently transfected with K14-Venus1Flag-N and analyzed after 48 hours of transfection. 
Absence of the green signal for YFP indicates there is no nonspecific signal from the YFP-Venus1 fragment. Scale 
bar 10 μm 
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4.2.2.3 Cotransformation of full length cDNA inserted and empty Venus plasmids 
 
Venus plasmids inserted with full length cDNAs were cotransfected with their corresponding 
empty Venus vectors containing the Venus-YFP moiety required for the reconstitution of full 
length active YFP. In this set of experiment K14-pVen1flag was cotransfected with pVen2 HA 
and empty pVen1flag with out K14 was contransfected along with AP2β-pVen2 HA, to check 
for any nonspecific interactions between the Venus1-YFP and Venus2-YFP fragments or 
between expressed proteins (K14/AP2β) and Venus-YFP fragment.  The results clearly indicated 
the absence of any non specific interactions in between either two Venus-YFP fragments or with 
the expressed protein (figure 4.14). 
 
Figure 4.14: Negative control for BiFC analysis of transiently transfected MCF7 cells. 
a & a` : MCF7 cells were cotransfected with AP2β-Venus2HA-C and empty Venus vector with the complementing 
half of the YFP pVenus1Flag-N, analyzed after 48 hours of transfection. Absence of the green signal for YFP 
indicates that the two complementing halves of the YFP do not form active YFP in presence of the fusion protein 
and it also doesn’t interact with AP2β fused to Venus2 half of the full length YFP. 
b & b` : MCF7 cells were cotransfected with K14-Venus1Flag-N and empty Venus vector with the complementing 
half of the YFP pVenus2HA-C, analyzed after 48 hours of transfection. Absence of the green signal for YFP 
indicates that the two complementing halves of the YFP do not form active YFP in presence of the fusion protein 
and it also does not interact with K14 fused to Venus1 half of the full length YFP. Scale bar 10 μm 
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Different sets of the above shown control experiments confirmed that, autofluorescence emitted 
by cotransfection of  Venus constructs tagged to K14 and AP2β is only due to the direct 
interaction of K14 and AP2β thereby reconstituting the mature Venus-YFP.  
These results confirm the interaction between two expressed proteins and strongly suggest that 
AP-2β is sequestered in the cytoplasm by interaction with K14 and also opens a new avenue for 
the first time to address a novel regulatory mechanism which controls the activity of AP-2β and 
possibly other AP-2 family members by interaction with keratins. 
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4.2.3 Confirmation of interaction between K14 and Rab34 by BiFC 
 
A member of Rab GTPase family protein Rab34 was identified as an interacting partner and 
confirmed for its association with K14 in yeast by two hybrid method. To investigate for 
existence of similar kind of affinity between the two proteins in mammalian cell culture model, 
which can shed light on involvement of keratins in vesicle transport by binding or harboring 
proteins involved in transport, Venus-YFP fragments were expressed in fusion with proteins 
under investigation. Upon cotransfecting these two constructs in MCF-7 mammary epithelial 
cells, full length active Venus-YFP was reconstituted emitting autofluorescence along the keratin 
filaments. 
In order to monitor the specificity of emitted fluorescence, different combinations of the 
expression plasmids (Table No. 4.9) were transfected in the experiment as controls.  
 
Sl.No Plasmid(s) transfected Group Fluorescence
1 K14-pVen1flag + Rab34-p ven2 HA Test + 
2 K14-pVen1flag Control - 
3 Rab34-p ven2 HA Control - 
4 K14-pVen1flag + pVen2 HA Control - 
5 pVen1flag + Rab34-p ven2 HA Control - 
Table 4.9: Different transfection groups used in experiment to confirm direct interaction of K14 with Rab34 
 
Full length K14 cDNA (1.73kb) was cloned in frame with amino terminal half of Venus1-YFP 
(first 480bp from total 747bp of Venus-YFP). Amino terminal of K14 was linked to carboxy end 
of Venus1-YFP fragment through ‘Flag’ tag which also to facilitates proper folding of Venus-
YFP fragment while reconstitution.  
 
Full length Rab34 cDNA (740bp) was cloned in frame with carboxy terminal half of Venus2-
YFP (last 267bp from total 747bp of Venus-YFP). HA tag was used to link carboxy end of 
Venus2-YFP fragment with amino terminal end of Rab34 which also helps in proper folding of 
Venus2-YFP fragment to reconstitute full length active Venus-YFP.  
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4.2.3.1 Cotransformation of full length cDNA inserted K14-pVen1flag and Rab34-pVen2 
HA plasmids 
 
Venus plasmids tagged with full length K14 and Rab34 were transiently cotransfected in MCF-7 
cells and observed for maturation of active Venus-YFP. Direct physical interaction of the two 
tagged proteins ensues the reconstitution of active Venus-YFP.  
Cotransformation of MCF-7 cells with K14-pVen1flag and Rab34-pVen2 HA plasmids followed 
by incubation at lower temperature to facilitate the maturation of Venus-YFP, reconstituted 
active Venus-YFP from amino and carboxy Venus fragments emitting clear autofluorescence 
indicating a direct interaction between K14 and Rab34. Emitted fluorescence was distributed 
evenly throughout the cytoplasm of transfected cells similar to cytoskeletal network of keratin 
filaments. 
Cotransformation efficiency of more than 40% was seen in all repetitive trials conducted to 
confirm the result. 
The autofluorescence emitted by the reconstitution of active Venus-YFP when cotransfected in 
MCF-7 cells strongly suggests that K14 binds to Rab34 and sequesters in cytoplasm of the cells 
(figure 4.15). 
  
 
Figure 4.15: BiFC analysis of transiently transfected MCF7 cells with RAB34 and keratin 14 Venus 
constructs. 
MCF7 cells were cotransfected with K14-Venus1Flag-N and RAB34-Venus2HA-C. Cells were fixed and analyzed 
after 48 hours of transfection. The green signal represents the YFP autofluorescence as a result of the formation of 
active YFP from the complementing halves due to the direct interaction between K14 and RAB34 which are fused 
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with the corresponding Venus halves. Distribution resembles to characteristic expression of endogenous keratin 
cytoskeleton. Scale bar 10 μm 
4.2.3.2 Individual transformation of full length cDNA inserted K14-pVen1flag and Rab34-
pVen2 HA plasmids 
 
Transfection of MCF-7 cells with Venus expression plasmids inserted with full length K14 and 
Rab34 was done individually to verify emittance of fluorescence from the individual Venus 
fragment in the absence of its complementing fraction which is necessary to form full length 
active Venus-YFP.  
The results indicated that upon transfection of Rab34-pVen2 HA and K14-pVen1flag, there was 
no non specific fluorescence emitted from the individual Venus-YFP fragments (figure 4.16). 
Transfection efficiency with eYFP plasmid ranged between 55 to 65 %. 
 
Figure 4.16: Negative control BiFC analysis of transiently transfected MCF7 cells with RAB 34 and keratin14 
Venus constructs. 
a & a` : MCF7 cells transiently transfected with RAB34-Venus2HA-C and analyzed after 48 hours of transfection. 
Absence of the green signal for YFP indicates there is no nonspecific signal from the YFP-Venus2 fragment. 
b & b` : MCF7 cells transiently transfected with K14-Venus1Flag-N and analyzed after 48 hours of transfection. 
Absence of the green signal for YFP indicates there is no nonspecific signal from the YFP-Venus1 fragment.        
Scale bar 10 μm 
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4.2.3.3 Cotransformation of full length cDNA inserted and empty Venus plasmids 
 
To confirm the result obtained in first part where it has shown the direct interaction between K14 
and Rab34 is genuine and not due to nonspecific interaction of expressed proteins with Venus-
YFP fragments, MCF-7 cells were cotransfected with K14-pVen1flag + pVen2 HA and Rab34-
pVen2 HA + pVen1flag Venus plasmids. 
The results clearly showed that, K14 tagged with Venus1 fragment does not interact with the 
Venus2 fragment in the absence of an interacting partner. The same was true for Rab34 tagged 
with Venus2 fragment (figure 4.17), which confirms the specificity of the detection system and 
thus the results obtained.  
 
Figure 4.17: Negative control for BiFC analysis of transiently transfected MCF7 cells. 
a & a` : MCF7 cells were cotransfected with RAB34-Venus2HA-C and empty Venus vector with the 
complementing half of the YFP pVenus1Flag-N, analyzed after 48 hours of transfection. Absence of the green 
signal for YFP indicates that the two complementing halves of the YFP do not form active YFP in presence of the 
fusion protein and it also doesn’t interact with RAB34 fused to Venus2 half of the full length YFP. 
b & b` : MCF7 cells were cotransfected with K14-Venus1Flag-N and empty Venus vector with the complementing 
half of the YFP pVenus2HA-C, analyzed after 48 hours of transfection. Absence of the green signal for YFP 
indicates that the two complementing halves of the YFP do not form active YFP in presence of the fusion protein 
and it also doesn’t interact with keratin14 fused to Venus1 half of the full length YFP. Scale bar 10 μm 
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BiFC analysis confirmed the direct interaction between cytoskeletal protein keratin14 and Rab34 
a transporter protein in the cytoplasm of MCF-7 cells. This result was supported by various 
control experiments conducted in parallel. 
The finding of interaction between K14 with transporter protein Rab34 will further support the 
recent reports stating the role of keratin in vesicle transport. Rab proteins (Rab27) are involved in 
melanosome transport and distribution in melanocytes, Rab34 being the member of same family 
and its interaction with K14 hints that, this specific interaction might be having some role to play 
in uptake and redistribution of melanosomes in keratinocytes. Further investigations towards this 
aspect would be highly significant to elucidate the role of keratins in melanosome transport and 
redistribution in keratinocytes.  
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4.2.4 BiFC analysis for verifying interactions between K14 with 14-3-3τ and p86DM 
Attempts to confirm the interaction of K14 with 14-3-3τ and p86DM in the similar lines to that 
of AP2β and Rab34 were not successful. Interaction of 14-3-3τ is dependent on phosphorylation 
of Ser33 like other members of 14-3-3 protein family. Since no artificial hyper-phosphorylation 
was induced in the experimental settings to look for the interaction, might be one of the reasons 
for not noticing the direct interaction with K14. 
Several experiments performed by co-workers showed that p86DM do not interact with K14 
directly. p86DM being identified for the first time, with its sequence analysis prediction pointing 
towards crucial role of this protein in many cellular process, led us to choose this protein for 
further investigation to characterize and to reveal its level of contribution in 
regulation/maintenance of cellular machinery.   
 
4.2.5 Analysis of p86DM 
Bioinformatic analysis of p86DM sequence identified in yeast two hybrid studies showed high 
level of sequence similarity with the sequence predicted in humans, mouse, fly and dog with the 
highest degree of identity being located at the C-terminus of coding sequence of orthologous 
proteins.  
In humans 5 transcript variants of different sizes ranging from 898bp to 2.5kb (figure 4.18) 
comprising 4 exons in the smallest and 10 exons in the larger sequence was predicted.   
 
12 3 4 5 7 8910
 - 77 -
  Results                
Figure 4.18: Sequence analysis of p86DM predicted 5 different transcript variants in humans with 4 to 10 
number of exons.  
4.2.5.1 Identification of p86DM coding sequence  
 
To verify whether p86DM is encoded by a single functional gene or by multiple genes as 
predicted, total RNA was isolated from mammalian intestinal Caco2 cells, subjected to RT-PCR 
amplification in order to isolate full length cDNA. Specific primers were designed for each of the 
predicted sequence and PCR amplified product yielded product with two different sizes, the first 
one being about 900bp and the second with size of 2.5kb. This result was in par with that of the 
predicted ones (figure 4.19).  
 
Figure 4.19: Size of PCR amplified cDNA products from Caco2 isloated RNA 
Lane a : marker, Lane b - e : PCR amplified products using specific primer. 
 
From the size profile obtained by PCR amplification using specific primers, it looked evident 
that the primers designed for different sized predicted genes, efficiently amplified the product. In 
order to confirm the amplified sequence, PCR amplified products were cloned into cloning 
vectors and transformed into E.coli. Column purified plasmid DNA was isolated from the 
transformed bacterial cultures.  
Two of the predicted p86DM coding genes were of sizes 2449 and 2491bp respectively with a 
mere difference of 42bp but the latter one having an additional restriction site ‘Ava I’. The 
obtained largest PCR amplified fragment with an approximate size of 2.5kb was cloned in clonig 
vector and was subjected to restriction analysis with ‘Ava I’. Restriction results revealed that, the 
amplified product did not contain the specified restriction site ‘Ava I’ and hence confirms the 
expression of 2449bp fragment in Caco2 cells (Figure 4.20). 
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Figure 4.20: Restriction analysis with Ava I to differentiate between the two transcripts 
Lane a : marker, Lane b &d : un cut plasmid inserted with PCR amplified product, Lane c & e: Plasmid restricted 
with Ava I enzyme   
The vector backbone in which the PCR amplified product was inserted contained an Ava I restriction site. The single 
band with the size of 5.4kb reveals that, there is no second Ava I restriction present in the construct.   
 
The PCR amplified fragments were sequenced and the results proved that p86DM is represented 
by only one functional gene, and the sequence of smaller fragments identified were found to be a 
part of 2.4kb gene identified.  
 
4.2.5.2 Functional Studies 
 
Bioinformatic analysis predicted a single transcript giving rise to an open reading frame of 776 
amino acids in the mouse. The predicted protein carries an N-terminal 14-3-3 binding site, SH2 
and SH3 motifs, a clathrin-heavy chain binding site, a coiled-coil domain and a C-terminal PDZ-
binding site. 
To elucidate the meaning of different predicted domains and in order to gain a first insight on the 
potential mechanism by which p86DM may act, a search for p86DM associated proteins was 
done. In this independent experiment, β-actin was identified as one of the p86DM interacting 
candidates.  
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Figure 4.21: Schematic representation of p86DM gene, transcript and protein 
A Human p86DM gene, on chromosome 10, encompasses ~110 kb with 9 exons. The coding sequence starts in exon 
4 and ends in exon 9. B Processed mRNA with a coding sequence (CDS) of 2337 bps C, D predicted domain 
organization of human and mouse p86DM, respectively. 
 
4.2.5.3 Interaction of p86DM with actin 
 
As a further step to confirm the results from above mentioned independent experiment, an 
attempt to confirm interaction between actin and p86DM in MCF-7 mammary epithelial cells by 
BiFC was done.  
In order to monitor the specificity of emitted fluorescence, different combinations of the 
expression plasmids (Table No. 4.10) were transfected in the experiment as controls.  
Sl.No Plasmid(s) transfected Group Fluorescence
1 p86DM-Ven1-N + Y-C-Actin Test + 
2 p86DM-Ven1-N Control - 
3 Y-C-Actin Control - 
4 Y-C-Actin + p Ven1-N Control - 
Table 4.10: Different transfection groups used in experiment to confirm direct interaction of p86DM with 
actin 
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Full length p86DM cDNA (2.4kb) was cloned in frame with amino terminal half of Venus1-YFP 
(first 480bp from total 747bp of Venus-YFP). Full length actin cDNA cloned in frame with 
carboxy terminal half of Venus2-YFP (last 267bp from total 747bp of Venus-YFP) was used.  
 
4.2.5.3.1 Cotransformation of p86DM-pVen1 and Y-C-actin plasmids 
 
In order to confirm the interaction of p86DM and actin in mammalian cell culture system, Venus 
expression plasmids inserted with full length p86DM and actin cDNA were cotransfected into 
MCF-7 cells. As a result of the direct interaction between the expressed proteins, Venus-YFP 
activity is reconstituted and led to accumulation of autofluorescence at the site of intracellular 
interaction (figure 4.22). A direct interaction was observed upon maturation of the YFP 
fluorescence spread all over cytoplasm of transfected cells. Cotransformation efficiency of more 
than 40% was seen in all repetitive trials conducted to confirm the result. 
The autofluorescence emitted by the reconstitution of active Venus-YFP when cotransfected in 
MCF-7 cells strongly suggests that actin directly interacts with p86DM.  
 
 
Figure 4.22: BiFC analysis of transiently transfected MCF7 cells with P86DM-Ven1-N and Y-C-actin Venus 
constructs. 
 
MCF7 cells were cotransfected with P86DM-Ven1-N and Y-C-Actin. Cells were fixed and analyzed after 48 hours 
of transfection. The green signal represents the YFP autofluorescence as a result of the formation of active YFP 
from the complementing halves due to the direct interaction between P86DM and actin which are fused with the 
corresponding Venus halves.  
a) Autofluorescence from the reconstituted Venus-YFP  b) MCF-7 cells with DAPI staining 
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4.2.5.3.2 Individual transformation of full length cDNA inserted p86DM-Ven1-N and Y-C-
actin plasmids 
 
Venus expression plasmids inserted with full length p86DM and actin were transfected 
individually into MCF-7 cells to check for emittance of false fluorescence signal from the 
individual Venus-YFP fragments. The results indicated that upon transfection of p86DM-Ven1-
N and Y-C-actin, there was no non specific fluorescence emitted from the individual Venus-YFP 
fragments (figure 4.23). Transfection efficiency with eYFP plasmid ranged between 55 to 65 %. 
 
Figure 4.23: BiFC analysis of transiently transfected MCF7 cells. 
a and a` : MCF7 cells transiently transfected with P86DM-Ven1-N and analyzed after 48 hours of transfection. 
Absence of the green signal for YFP indicates there is no nonspecific signal from the YFP-Venus1 fragment. 
b and b` : MCF7 cells transiently transfected with Y-C-Actin and analyzed after 48 hours of transfection. Absence of 
the green signal for YFP indicates there is no nonspecific signal from the YFP-Venus1 fragment. Scale bar 20 μm 
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4.2.5.3.3 Cotransformation of full length cDNA inserted and empty Venus plasmids 
 
To confirm the result obtained in first part where it has shown the direct interaction between K14 
and Rab34 is genuine and not due to nonspecific interaction of expressed proteins with Venus-
YFP fragments, MCF-7 cells were cotransfected with K14-pVen1flag + pVen2 HA and Rab34-
pVen2 HA + pVen1flag Venus plasmids. 
The results clearly showed that, K4 tagged with Venus1 fragment does not interact with the 
Venus2 fragment in the absence of an interacting partner. The same was true for Rab34 tagged 
with Venus2 fragment (figure 4.24), which confirms the specificity of the detection system and 
thus the results obtained.  
 
 
Figure 4.24: BiFC analysis of transiently transfected MCF7 cells. 
MCF7 cells were cotransfected with Y-C-Actin and empty Venus vector with the complementing half of the YFP 
pVenus1-N, analyzed after 48 hours of transfection. Absence of the green signal for YFP indicates that the two 
complementing halves of the YFP do not form active YFP in presence of the fusion protein and it also doesn’t 
interact with actin fused to second half of the full length YFP. 
a) Autofluorescence from the reconstituted Venus-YFP  b) MCF-7 cells with DAPI staining 
An antiserum against a highly conserved C-terminal motif of p86DM was raised to examine the 
intracellular localization and tissue distribution of p86DM, By Western blotting and peptide 
competition experiments, the antiserum was found to be highly specific and detected a 
polypeptide of Mr 86 kDa in cultured cells (Wester. A., and Magin. TM).  
To confirm the expression of p86DM and actin in cotransfected cells, cells were stained with the 
antiserum raised against p86DM and anti-YFP antibody which identifies the epitope on C-
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terminal of YFP to look for the expression of actin. Staining images (Figure 4.25) supported the 
Venus-YFP fluorescence profile exhibited in BiFC experiments thereby confirming the 
interaction between p86DM and actin. 
 
Figure 4.25: BiFC analysis along with staining of transiently transfected MCF7 cells. 
MCF7 cells were cotransfected with p86DM-Ven1-N and Y-C-Actin. Cells were fixed and stained after 48 hours of 
transfection. Scale bar 10 μm. 
a: Red signal represents expression of p86DM from the transfected p86DM-Ven1-N plasmid. 
b: Transfected  cells stained against C-terminal half of YFP using anti-YFP antibody. Blue signal represents 
expression of actin–YFP fragment fusion protein from Y-C-Actin plasmid 
c: The green signal represents the YFP autofluorescence as a result of the formation of active YFP from the 
complementing halves due to the direct interaction between p86DM and actin which are fused with the 
corresponding Venus halves.  
d: Mergerd signals from p86DM stained red, actin-YFP with blue and Venus- YFP autofluorescence from 
reconstituted Venus –YFP. 
 
4.2.5.4 Expression of recombinant p86DM 
For further investigation of functional significance and to elucidate the structural properties of 
p86DM, it was expressed as a recombinant protein in E.coli. Full length p86DM was cloned in 
frame with pET-SUMO expression vector in which p86DM was expressed as N-terminal SUMO 
fusion. Expression was optimized by testing different strains of E.coli at different induction 
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temperatures. It was observed that E.coli strain ‘Rosetta’ was most suitable when expression was 
induced at 27°C (figure 4.26). Purification of the expressed fusion protein was optimized by 
altering down stream processing conditions at various points.  
 
Figure 4.26: Expression profile of p86DM after 210 min of induction at 37oC and 27oC 
p86DM was expressed as fusion protein with SUMO and His tags in Rosetta bacterial strain.   
 
Purified protein with intact His tag can be used for further binding studies, His sumo tag was 
cleaved off by exposing to sumo protease, an enzyme which identifies the tertiary structure of the 
ubiquitin-like (UBL) protein and cleaves in a highly specific manner. 
 
Figure 4.27: western blot analysis of recombinantly expressed p86DM followed by SUMO protease treatment 
to His-SUMO tag 
 
Lane a & b: Coomassie staining of supernatant of cell lysates expressing recombinant p86DM in fusion with HOS-
SUMO tag, Lane c & d: Coomassie staining of elutes treated with SUMO protease enzyme, Lane e : Marker, Lane f 
& g: Immuno blot of supernatant of cell lysates expressing recombinant p86DM in fusion with HOS-SUMO tag, 
Lane h & i: Immuno blot of elutes treated with SUMO protease enzyme. 
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5.  Discussion 
 
In order to understand how keratins act at the molecular level and how mutations in keratins 
cause pathological alterations, it is essential to have an in-depth understanding of keratin 
structure and its associated proteins. At the start of the work done in this thesis, very few keratin-
associated proteins were known, including the structural proteins desmoplakin, filaggrin and 
plectin. The major work was to identify keratin-associated proteins which might act together 
with keratins to execute its actions beyond maintenance of cyctoarchitecture and might provide 
insight to molecular mechanisms responsible for functions of keratins in normal and diseased 
keratinocytes.  
Keratins, being the major intermediate filament proteins of epithelia, display an outstanding 
degree of molecular diversity. The 54 human keratin genes which have been identified till date 
are expressed in highly specific patterns related to epithelial and stage of cellular differentiation, 
major of them being restricted to various compartments of hair follicles. 
In the present study major focus was on epidermal keratins, K5 and K14. 
K5 and K14 are expressed in the undifferentiated basal keratinocytes of stratified epithelium 
(Fuchs and Green, 1980), stratified follicular outer root sheath, basal and myoepithelial cells of 
complex glandular epithelial tissue (Purkis et al., 1990). During the process of terminal 
differentiation, expression of K5 and K14 is downregulated and a new set of keratins, K1 and 
K10 are expressed in the suprabasal spinous layer (Byrne et al., 1994). Most important function 
of K5 and K14 is to provide mechanical stability to epithelial cells and apart from this, these 
keratins have shown to be involved in other functions like vesicle transport. Mutations in genes 
encoding K5 and K14 lead to several skin disorders like Epidermolysis bullosa simplex (EBS), 
Naegeli-Franceschetti-Jadassohn syndrome (NFJS), Dermatopathia pigmentosa reticularis (DPR) 
and Dowling-Degos Disease (DDD). Thereby it raises the need for a detailed study in order to 
reveal the functions of keratins and keratin associated proteins, during physiological and 
pathological situations. 
A closer look at the diseases caused due to mutations in K5 and K14 reveals that more disorders 
arise from mutation in K5 than from K14 and certain disorders like Dowling-Degos Disease 
(DDD) arise from K5 but not from K14, and disorder Recessive EBS-WC arises from due to 
mutated K14. This raises the question whether in a pair, both partners have the same function. 
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In order to verify keratin-associated proteins, we have performed screening studies cDNA library 
constructed with 500,000 cDNA fragments isolated rom human skin sample. These fragments 
were inserted randomly in yeast expression vector. 
The screening was done using a novel genetic screening method ‘Sos recruitment system’’ in 
which the proteins like transcriptional activators/repressors, proteins that require post 
translational modification in the cytoplasm and the proteins /protein complex that are toxic to 
yeast can be identified which is not possible in the former Y2H screening techniques. 
In this system, temperature sensitive yeast strain S.cerevisiae which carries mutated CDC45 
gene, a homolog of human Sos protein. Bait is expressed as hSos fusion protein and prey is 
expressed as Myr fusion protein – myristylation signal containing gene. Upon physical 
interaction between the bait and the prey, anchors hSos to membrane there by activating the Ras 
signalling pathway which in turn enables the yeast to grow at restrictive temperature 37oC. 
All keratins have similar domain structure with a α-helical rod, flanked by non-helical head and 
tail domains. Type I and type II keratins form obligatory heterodimers via their highly conserved 
rod domains among different of keratins which are interrupted by non-α-helical linker 
sequences. The positively charged head domain permits the formation of filaments via 
antiparallel tetramers, while tail regulates the lateral association of individual filaments into 
bundles.  
A significant similarity of 70% in the amino acid sequence was observed between the rod 
domains of stratified epithelial keratins K5/K14 with their embryonic and simple epithelial 
keratins K8/K18, where as sequences of head tail domains share only about 30%. 
To get an insight into the differential properties of different keratin domains, head, rod and tail 
domains of K5 and K14 were individually expressed as fusion proteins with hSos and co-
transformed along with cDNA library fragment containing pMyr. 
The putative positive interacting candidates, which were isolated in the preliminary screening 
procedure, were confirmed for the interaction in yeast by replica plating on to the selective media 
followed by incubation at restrictive temperature. 
More than 2400 interacting candidates were confirmed by yeast two hybrid screening were 
obtained from screening of 6 domains in-total of K5 and K14. 
The purified plasmid DNA of these interacting yeast colonies was sequenced followed by 
bioinformatics analysis to identify the interacting candidates. Few of them are listed in the results 
section table 4.4 and table 4.5 
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Figure 5.1: Domain sequence coparison of K5/ K14 with K8/K18. Rod domains showed greater 
similarities and are more consereved than head and tails domains. 
 
We could identify wide array of proteins with diverse functions like calcium binding proteins: 
calponin, calmodulin, annexin, transporter proteins like GTPase family members proteins like 
Rab34, EP164 which play a direct role in vesicle transport. Membrane binding proteins like 
LYPD3, WW domain binding proteins like WBP1, TAPT1. Transcription factors like AP2ß, 
STAT6, translation elongation factor like EEF1A1, peroxyredoxin family of antioxidant 
enzymes like PRDX5 which reduce hydrogen peroxide to alkyl hydroperoxides and may play 
any antioxidant protective role in different tissues under normal conditions and during 
inflammatory process. Adapter protein 14-3-3 along with many hypothetical and un-annotated 
proteins were identified, out of which P86DM  raises a special interest as bioinformatics domain 
analysis predicts to be involved in the cell polarity and migration of the cells. Disruption of the 
interaction between keratins and translation elongation factor (eEF1Bγ) depresses translation by 
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20% with the selective increase of 80S ribosomes in epithelial cells, which establish that the 
keratin cytoskeleton and protein synthesis machinery are functionally integrated (Kim et al., 
2007). 
Among the 40 listed candidates, RAB34, 14-3-3 theta, AP2β and P86DM were selected for 
further analysis and confirmation of their interaction with keratins in mammalian cell culture 
system. 
To confirm the interaction in the mammalian cell system, bimolecular fluorescence 
complementation (BiFC) technique was used, which is based on the principle of formation of a 
mature fluorescent YFP from the two non-fluorescent fragments of YFP which are fused with the 
proteins whose interaction has to be studied. The physical interaction of the two proteins brings 
together the non-fluorescent fragments of YFP and forms a functionally active fluorescent 
complex. This method detects the direct physical interactions and has the advantage that 
autofluorescence reveals the confirmation of interaction thereby rendering the staining of cells 
non-essential.  
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Keratins and 14-3-3τ 
 
Using ‘Sos recruitment system’ Theta isoform of 14-3-3 family of proteins has been identified as 
one of the interacting candidate with K14 head domain.  
14-3-3 proteins were first described in the brain (Moore and Perez, 1967) and include seven 
members (β, γ, , η, σ, τ and ζ) that range in size between 28 and 33 kDa. 14-3-3 proteins are 
important regulators which are involved in many cellular processes like cell cycle regulation 
(Bridges and Moorhead, 2004; Hermeking, 2003; Hermeking and Benzinger, 2006) signal 
transduction and stress response (Fu et al., 1994; Yoshida et al., 2005), apoptosis (Datta et al., 
2000), transcriptional regulation (Brunet et al., 2002), co-ordination of cell adhesion and motility 
(Santoro et al., 2003).  
14-3-3 proteins regulate many cellular processes by binding to phosphorylated sites in diverse 
target proteins (Tzivion and Avruch, 2002). In general interaction of 14-3-3 proteins with target 
proteins is generally mediated through two canonical 14-3-3-binding motifs RSXpS/TXP or 
RXXXpS/TXP sequences, in which ‘X’ denotes ‘any amino acid residue’ and pS/T is 
phosphorylated (Yaffe, 2004).  
To confirm the interaction between K14 and 14-3-3τ , bimolecular fluorescence 
complementation technique (BiFC) which allows visualizing the direct interactions was used. 
Upon co-transfection of Venus-tagged 14-3-3τ and K14 cDNAs into MCF-7 mammary epithelial 
cells, no fluorescence signal was observed which hinted towards absence of direct interaction 
between K14 and 14-3-3τ.  
But it has been shown that 14-3-3 family proteins bind to keratin 18 in phosphorylation 
dependent manner with the mandatory phosphorylation of Ser33 for the association. Moreover 
the interaction of K18 with 14-3-3 proteins was observed only under induced 
hyperphosphorylated conditions by subjecting the transfected cells to heat or ocadiac acid 
treatment (Ku et al., 1998; Liao and Omary, 1996). 
In the present study experimental settings with minimal deviation from normal physiological 
conditions were used to detect interaction between K14 and 14-3-3τ. It is possible that the 
stoichiometry of basal phosphorylation might be low in the cells studied here, which might be 
acting as a limiting factor for the interaction of the transfected Venus tagged K14 and 14-3-
3τ proteins.  
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Keratins and Rab34 
 
With the growing list of keratin-based genetic diseases hint at the role of keratins in skin 
pigmentation.  EBS with mottled pigmentation (EBS-MP) is a rare EBS subtype, giving the skin 
a mottled appearance exhibiting hyper / hypo-pigmented skin. Until recently, all cases of EBS-
MP had been linked to a single missense allele, P25L, in K5 (Uttam et al., 1996), which no 
longer might be true, since a missense mutation in the a-helical rod domain of K14, M119T 
(Harel et al., 2006), as well as the 1649delG mutation in K5 were reported with telltale signs of 
EBS-MP (Horiguchi et al., 2005). Patients suffering from EBS-MCE develop hyper- or hypo-
pigmented patches as adults (Gu et al., 2003). Dowling-Degos disease (DDD) is typified by 
reticulate hyperpigmentation along with dark hyperkeratotic papules in skin known to be caused 
because of K5 haploinsufficiency (Betz et al., 2006). Naegeli–Franceschetti–Jadassohn 
syndrome caused by mutations located early in the head domain of K14 (Lugassy et al., 2006) 
causes mottled hyperpigmentation of the skin. Although the mechanism remains unclear, 
evidence supporting a novel role for keratin proteins in regulating skin pigmentation reveals that 
premature stop codons in the K5 gene affect melanosome distribution in keratinocytes (Betz et 
al., 2006; Liao et al., 2007). Also genetic mouse models with chemically induced mutations 
identify involvement of keratins in coat color determination (Fitch et al., 2003; McGowan et al., 
2006; McGowan et al., 2007). 
With all the above findings pointing towards the disturbed redistribution of melanosomes in skin, 
it becomes very important and interesting to understand the underlying mechanism in uptake of 
melanin granules packed in membrane-bound organelles termed ‘melanosomes’ from 
melanocytes - a neural-crest-derived, highly dendritic cell type to the neighboring keratinocytes 
and redistribution in keratinocytes. One hypothesis for melanosome uptake is endocytotic 
process and the redistribution through various transporter / motor proteins. 
In the process of identifying keratin associated proteins, we have identified the protein Rab34 a 
member of small GTPases of ras superfamily as interacting partner of K14 head domain using 
Sos recruitment system. 
Rab proteins are small GTPases of the ras superfamily that confer timing and target specificity to 
vesicle budding, tethering, docking, fusion, play essential roles in the endocytic and exocytic 
processes of transport vesicle formation within the eukaryotic secretory and endosomal pathways 
(Segev, 2001; Somsel Rodman and Wandinger-Ness, 2000; Zerial and McBride, 2001). They 
thus ensure accurate delivery of cargo macromolecules to the right target organelle. Most 
mammalian rabs are broadly expressed and regulate membrane transport between ubiquitous 
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compartments, such as endoplasmic reticulum and the golgi apparatus. However, certain cell 
types in higher eukaryotes harbor additional unique organelles that carry out tissue-specific 
functions. The best characterized are so-called lysosome-related organelles, which include 
melanosomes, the pigment organelle of melanocytes and of pigment epithelia in the eye. These 
proteins are also associated with particular vesicle membrane compartments and function in 
specific stages of the diverse vesicle trafficking events.  
Rab34 is a 29-kDa protein present both in the cytosol and in the Golgi apparatus. Rab34 is 
present in the Golgi apparatus and cytosol (Wang and Hong, 2005) and it interacts with Rab7-
interacting lysosomal protein (RILP) to regulate the morphology and spatial distribution of 
lysosomes(Wang and Hong, 2002). Rab34 is involved in the regulation of lysosome 
morphogenesis through cooperation with the dynein–dynactin complex (Jordens et al., 2001) 
Rab34 plays a crucial role in facilitating the formation of macropinosomes from the membrane 
ruffles (Wang and Hong, 2005). Rab34 is colocalized with actin to the membrane ruffles and 
macropinosome membrane (Sun et al., 2003). During macropinocytosis, Rab34 is associated 
with nascent macropinosomes and replaced by Rab5 at later stages. Overexpression of Rab34 
elevates the number of macropinosomes, whereas the expression of a dominant-negative Rab34 
prevents macropinosome formation induced by platelet-derived growth factor (PDGF) or PMA. 
The direct interaction between Rab34 and K14 in the mammalian cell system was confirmed 
using bimolecular fluorescence complementation (BiFC) in cytoplasm of human MCF-7 cells. 
Non fluorescent fragments of Venus were tagged to Rab34 and K14 cDNAs. Upon co-
transfection into MCF-7 mammary epithelial cells, a direct physical interaction between the two 
proteins was observed in the form of autofluorescence emitted by the reconstituted mature YFP 
(Figure: 4.15). In endogenously keratin expressing MCF-7 cells K14 gets incorporated with the 
other type II keratins like K8/K9 to form the filamentous structure (Planko et al., 2007; Werner 
et al., 2004). Control transfections with empty vectors revealed no interaction, demonstrating the 
specificity of the interaction. 
These data strongly suggest that Rab34 a member of transporter protein family directly interacts 
with K14. Understanding the significance of this interaction and further in-depth studies might 
definitely help in knowing process of import and regulation of melanosome by keratinocytes. 
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Keratins and AP-2β 
 
The transcription factor family AP-2 consists of upto five members which are known to exhibit a 
highly homologous structure. AP-2 proteins form homo- or hetero-dimers with other AP-2 
family members and bind specific DNA sequences. They are thought to stimulate cell 
proliferation and suppress terminal differentiation of specific cell types during embryonic 
development. Specific AP-2 family members differ in their expression patterns and binding 
affinity for different promoters. This protein functions as both a transcriptional activator and 
repressor, however their functions are considered to be different (Eckert et al., 2005). In skin AP-
2β is expressed in the basal layer while AP-2β is restricted to the sweat glands and AP-2γ is 
found in basal, spinous and granular layers (Byrne et al., 1994; Oyama et al., 2002; Panteleyev et 
al., 2003; Takahashi et al., 2000). 
A role of AP-2 in epidermal differentiation is substantiated by studies of embryonic and adult 
skin in Xenopus demonstrate that the keratin gene-regulatory factor KTF-1 is identical with or 
closely related to AP-2 (Snape et al., 1991; Winning et al., 1991). This factor, also known as 
KER1 from human keratinocytes, is involved in regulation of keratin gene promoters during 
epidermal differentiation (Leask et al., 1991). The keratin proteins K1, K5, K10 and K14 as well 
as the EGFR which play a critical role in epidermal development and differentiation have been 
shown to harbor functional AP-2 binding sites in their promoters (Byrne et al., 1994; Koster et 
al., 2006; Leask et al., 1991; Maytin et al., 1999; Wang et al., 1997). Analysis of murine 
embryonic skin development revealed that AP-2 mRNA is expressed in a pattern similar to, but 
preceding that of basal keratin mRNAs (Byrne et al., 1994). Most recently, the conditional 
ablation of both AP-2α and γ has demonstrated their major role in terminal differentiation in skin 
epidermis (Wang et al., 2008). 
The 5 members of the AP-2 family of helix-span-helix transcription factors determine the cell-
type-restricted proliferation and the suppression of terminal differentiation of epithelia and 
additional tissues. Regulation of activity of AP-2 proteins still not well known. 
All together more than 50 different type I and type II keratins form the major cytoskeleton of 
epithelial cells and are differentially expressed in all epithelia, creating protein scaffolds with 
unique properties. In addition to their well-established function as cytoskeletal scaffolds in 
epithelia, the disruption of which affects cytoarchitecture, recent papers have been reported 
establishing novel and unexpected keratin functions in cell proliferation, growth, survival and 
organelle transport. 
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In the yeast two hybrid screening for keratin associated proteins, we have isolated a clone 
encoding for the transcription factor AP-2β as a binding partner for the K14 head domain. Full 
length AP-2β cDNA was provided by Prof. Dr. Hubert Schorle, Bonn, was used for the further 
experiments. 
The direct interaction between AP-2β and K14 was confirmed using bimolecular fluorescence 
complementation (BiFC), in the cytoplasm of human MCF-7 cells.  
Upon co-transfection of Venus-tagged AP-2β and K14 cDNAs into MCF-7 mammary epithelial 
cells, a strong interaction between the two proteins was apparent that was highly reminiscent of 
staining these cells with a keratin antibody (Figure: 4.12). In fact, MCF-7 cells form an extensive 
cytoskeleton from endogenous keratins in which K14 becomes incorporated following 
transfection(Planko et al., 2007; Werner et al., 2004). Control transfections with empty vectors 
revealed no interaction, demonstrating the specificity of the interaction. These data strongly 
suggest that AP-2β is sequestered in the cytoplasm by interaction with K14. 
In eukaryotes, transcription factors (like most proteins) are transcribed in the nucleus but are then 
translated in the cell's cytoplasm. Many proteins that are active in the nucleus contain nuclear 
localization signals that direct them to the nucleus. But for many transcription factors this is a 
key point in their regulation. Important classes of transcription factors such as some nuclear 
receptors must first bind to a ligand while in the cytoplasm before they can relocate to the 
nucleus. 
We hypothesize that sequestration by distinct keratins represents a novel mechanism to regulate 
the activity of AP-2 transcription factors. 
AP-2β can be a potential drug target as therapeutic agent in treatment of cancer (Deng et al., 
2007). It has been validated as direct target gene mediating the anti-apoptotic function of 
PAX3/FKHR with a well known oncogenic role (Ebauer et al., 2007). AP-2 has been implicated 
to play a role in carcinogenesis, as well as in the development of the kidney. AP-2β expression 
was observed in the low-stage subtypes of renal cell carcinoma (Oya et al., 2004). AP-2β  is 
reported to be a promising target for treatment of type 2 diabetes where it is known to regulate 
adipocytokine gene expression contribute to the pathogenesis of type 2 diabetes through 
regulation of adipocytokine gene expression, and that AP-2β  may be a promising target for 
treatment or prevention of this disease (Maeda et al., 2005; Tsukada et al., 2006). 
To understand and to elucidate the functional role of interaction between K14 and AP-2β , it 
becomes important to look for the molecular mechanism for the long-proposed scaffolding role 
of keratins and the signalling pathways regulate the AP-2β – K14 interaction. 
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Analysis of p86DM 
 
We have isolated an unannotated protein as keratin associated protein using a genetic screening 
method ‘Sos recruitment system’ in yeast. We found this protein as interacting partner with K14 
head and rod domain. Unfortunately the effort to prove its direct interaction with K14 in 
mammalian cell culture system using BiFC was not successful. At present, it appears that 
p86DM does not directly interact with K14, based on a number of experiments carried out by 
others in the lab. 
p86DM still being  unannotated in the database and sequence analysis of p86DM using 
bioinformatics tools predicted interesting functions like role in endocytosis, migration and 
regulation of tight junctions with relevant domains in its sequence. The predicted protein carries 
an N-terminal 14-3-3 binding site, SH2 and SH3 motifs, a clathrin-heavy chain binding site, a 
coiled-coil domain and a C-terminal PDZ-binding site, a domain organization similar to that of 
TJ-associated proteins. 
These factors (see above) made us to select this protein for further investigation despite being not 
successful to identify the direct interaction in mammalian cells as the indirect interaction with 
functional significance cannot be ruled out.   
Bioinformatics analysis predicted a single transcript giving rise to an open reading frame of 776 
amino acids in the mouse and 5 isoforms for human p86DM gene. To verify whether p86DM is 
encoded by a single functional gene, total RNA was isolated from Caco-2 cells, full length 
cDNA was obtained by performing RT-PCR using the different set of primers according to the 
predicted isoforms with a coding sequence of 2337bp located in between exon 4 and exon 9. The 
multiple length cDNAs obtained by RT-PCR were sequenced and their analysis showed 
existence of a single functional gene for p86DM in cultured Caco-2 cells.    
In order to gain a first insight on the potential mechanism by which p86DM may act, in an 
independent experiment (Wester.A and Magin.T.M) β-actin was identified as one of the p86DM 
associated proteins. 
Immunofluorescence anylaysis in cultured epithelial cells demonstrated that at the apical 
plasmam membrane P86DM colocalized with actin at tight junctions (personal communication 
with Wester.A and Magin.T.M). The eukaryotic actin cytoskeleton has an important role in 
remarkable diverse processes, including cell migration, endocytosis, vesicle traffiking and 
cytokinesis, many of which are essential for survival of the cell (Goley and Welch, 2006). The 
dynamic assembly and disassembly of actin filaments and the formation of larger scale filament 
 - 95 -
  Discussion                
structures are crucial aspects of actin’s function, and are therefore under scrupulous control by 
over a hundred actin-binding proteins.   
To investigate the interaction of p86DM with candidate proteins, its interaction with actin was 
investigated further. For this purpose we once again used BiFC technique which has successfully 
demonstrated the direct interactions between two proteins in previous experiments. Full length 
actin and p86DM were tagged with the non-fluorescent fragments of Venus-YFP, upon 
cotransfection in MCF-7 cells, autofluorescence as a result of formation of mature YFP revealed 
the interaction between actin and p86DM (Figure: 4.22). The cotransfected cells were stained for 
actin and p86DM, their staining profile and the images (Figure: 4.25) further supported the 
results obtained from BiFC experiment thereby confirming the interaction between actin and 
p86DM. 
To carry out the further functional studies for p86DM, recombinant protein was expressed in E. 
coli with the SUMO-His tag (Figure: 4.27), which will be used in the further functional studies. 
The purified protein which has been cleaved off from SUMO-His tag, can be used for structural 
analysis and to raise p86DM specific monoclonal antibody.   
Based on the preliminary set of results from the functional studies, p86DM enjoys the status of a 
promising candidate and requires thorough investigation to reveal the importance of its direct 
interaction with actin which might be involved in the local regulation of actin organization.   
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6. Summary 
 
Keratins are an integral and important constituent of the epithelial cytoskeleton and protect 
epithelial cells against stress. In addition to their well-established function as cytoskeletal 
scaffolds in epithelia, recent findings have revealed that beyond maintenance of cytoarchitecture, 
keratins play important role in cell proliferation, growth, survival and organelle transport along 
with its associated proteins. To understand these novel keratin functions and to address the 
molecular mechanisms, the identification of keratin-associated proteins was a major prerequisite.  
The aim of the present study was to find novel keratin associated proteins that might provide 
missing links. To this end, screening for the KAPs was carried out by a genetic approach ‘Sos 
recruitment’ technique based on temperature sensitive selection of positive interacting candidates 
in yeast to isolate K5 and K14 interacting proteins. As the first step, cDNA library was 
constructed with 500,000 cDNA fragments (size ranging from 500 bp to 4 kb) isolated from 
human skin sample. Yeast-two-hybrid screen was performed using head, rod and tail domains of 
epidermal keratins K5 and K14 as baits against cDNA library.  
Screening in yeast yielded more than 2400 interacting candidates, out of which 200 selected 
cDNA fragments were sequenced.  
It was observed that proteins affiliated with diverse functions seem to interact with K5 and K14. 
To name a few, small GTPase family members proteins (Rab34, EP164), membrane binding 
proteins (LYPD3), WW domain binding proteins (WBP1, TAPT1 etc), transcription factors 
(AP2β, STAT6), translation elongation factor (EEF1A1), 14-3-3theta a member of 14-3-3 family 
proteins along with many hypothetical and un-annotated proteins like p86DM were identified as 
interacting partners. 
K14 head domain interacting candidates ‘Rab34’ a small GTPase of the ras superfamily reported 
to be involved in the regulation of lysosome morphogenesis (Jordens et al., 2001) and in 
formation of macropinosomes (Wang and Hong, 2005), regulator protein ‘14-3-3 theta’, 
transcription factor ‘AP2-β’ a member AP-2 family of helix-span-helix transcription factors 
which determine the cell-type-restricted proliferation and the suppression of terminal 
differentiation of epithelia and additional tissues, and the anannotated protein ‘p86DM’  were 
selected for further analysis.  
A direct interaction of full length K14 with AP-2β, and Rab34 was confirmed in cytoplasm of 
mammary epithelial MCF-7 cells by bimolecular fluorescence complementation (BiFC) 
technique.   
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These results strongly suggest: 
1. Ras-related protein Rab-34 belonging to small GTPase Rab family directly interacts with 
K14. Understanding the significance of this interaction and further in-depth studies might 
definitely help in knowing process of import and regulation of melanosome by keratinocytes. 
2. Direct interaction between K14 with AP-2β strongly suggests that AP-2β is sequestered in 
the cytoplasm by interaction with K14 and can be hypothesized that sequestration by distinct 
keratins represents a novel mechanism to regulate the activity of AP-2 transcription factors. 
3. Preliminary set of results from the functional studies of p86DM displayed encouraging 
results and thus can be considered as a promising candidate and requires thorough 
investigation to reveal the importance of its direct interaction with actin.   
It is worthwhile to note that, for the first time a detailed screen has been undertaken to identify 
keratin-associated proteins and less than 10% of the candidates obtained from Y2H screen have 
been sequenced so far. Further analysis of the already identified proteins and identifying the 
preserved un-sequenced samples will be beneficial towards understanding the molecular 
mechanism of keratin regulated functions. 
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PROJECTS 
 
1. Identification and characterization of novel keratin associated proteins using a genetic 
interaction screening system 
Institue of Physiological chemistry 
Guide : Prof. Thomas M. Magin 
Brief project profile:  
Cell architecture is mainly based on the interaction of cytoskeletal proteins, which include 
intermediate filaments, micro filaments, microtubules as well as type-specific membrane 
attachment structures and associated proteins. 
Keratin 5 and keratin 14 form the major intermediate filaments of basal epidermis, their primary 
function is to impart mechanical strength to cells as highlighted by the dominant mutations 
causing inherited skin disorders. In order to understand the molecular mechanism of keratin 
dependent functions, we intend to identify novel keratin associated proteins. 
Yeast two hybrid screen was performed using K5 and K14 as bait against a cDNA library prepared 
from human skin tissue. From the six baits used about 2000 positive interacting candidates were 
obtained, which included anticipated transporter proteins along with some unexpected and un-
annotated proteins.  
Among the different methods tested to confirm the interaction between positive candidates from 
the screen and keratins, bimolecular fluorescence complementation (Bifc) was found to be the 
most suitable method and thus was used to confirm the interaction for some of the short listed 
candidates. At present further functional studies are being carried out for characterization of some 
of the selected interacting candidates identified by screening experiments. 
 
2. Evaluation of estrogenic activity using MCF -7 human breast cancer cells 
Natural Remedies Ltd., Bangalore, INDIA.  Team size: 1 
Brief project profile:   
This project is focused on discovering the potent phytoestrogens from the herbal extracts. 
Estrogenic activity is determined using an estrogen-dependent MCF-7 breast cancer cell 
proliferation assay. 
 
3. Nitric oxide scavenging activity in freshly isolated  macrophages 
Natural Remedies Ltd., Bangalore, INDIA.  Team size: 1 
Brief project profile:   
A mixture of water extracts of certain medicinal plants is being investigated for the nitric oxide 
scavenging activity in freshly isolated macrophages from the peritoneal cavity of mice. The nitric 
oxide release is stimulated using lipopolysaccharide (LPS) & the extract mixture is being tested 
for its scavenging activity by a microtitre plate assay method based on Griess reaction. 
 4. Evaluation of anti-hyperglycemic effect of herbal extracts through the inhibition of intestinal 
enzymes in normal rats. 
Natural Remedies Ltd., Bangalore, INDIA.  Team size: 1 
Brief project profile:   
We examined the inhibitory effects of different herbal extracts on starch and sucrose loading 
induced hyperglycemia in normal Wistar rats. Blood glucose level was estimated at different 
intervals after the carbohydrate loading to examine the inhibitory activity of the test extracts on 
disaccharidases in the small intestine of rats. 
 
5. Evaluation of anti stress property by swim endurance test 
Natural Remedies Ltd., Bangalore, INDIA.  Team size: 1 
Brief project profile:   
The anti stress property of the herbal extracts was tested on Swiss albino mice, exposed to swim 
endurance test model of stress. Positive control compound and the test extracts were administered 
orally for 30 days. Reactivity of the mice, loss in body weight, length of endurance and incidence 
of mortality were graded and measured. 
 
6. Method Development For Isolation And Purification Of HBsAg Protein  
Yashraj Biotechnology Ltd., New Bombay, INDIA.  
 Brief project profile:   
The project involves the method development for isolation & purification of the diagnostically 
important proteins (HBsAg, Cancer antigens) from the biological fluids of human origin, scale-up 
to production process & the study of stability properties of the purified proteins. 
7. Tool for finding ORF in a nucleotide sequence. 
Manvish InfoTech Ltd, Bangalore, INDIA,. 
Guide: Dr. Raja Mugasimangalam. Team size: 3 
Brief project profile:   
A tool was developed using C programming language, to locate the Open Reading Frames (ORF) 
and its position in the original nucleotide sequence, along with six frame translations.  The results 
obtained from this tool were similar to that of the currently available online tools.  As a useful 
analytical tool, it also provided the percentage GC content. This utility is a useful and fast way to 
translate a sequence in combination with ORF analysis.  
8. In-vitro and in-vivo investigation on the hepatoprotective activity of certain medicinal    
plants. 
J.S.S College of Pharmacy, Ooty,  
Guides :Dr.P.Vijayan. Team size: 1  
Brief project profile:  
The methanolic extracts of the root, root bark and stem of Berberis tinctoria, ethanolic extract of 
whole plant of Phyllanthus amarus and the total alkaloids isolated from the leaves of Solanum 
pseudocapsicum were investigated for its hepatoprotective activity against CCl4 induced toxicity 
in freshly isolated rat hepatocytes, HepG2 cell line in-vitro and in animal models. The extracts 
were able to normalise the levels of ASAT, ALAT, ALP, TGL, total proteins, albumin, total 
bilirubin and direct bilirubin which were altered due to CCl4 intoxication in freshly isolated rat 
hepatocytes and also in animal models.  
 
9. Comparative cytotoxic studies of synthetic drugs in established cell lines and primary 
culture. 
J.S.S College of Pharmacy, Ooty,  
Guide : Dr. P. Vijayan & Ms. Sarita G.S  Team size : 2  
Brief project profile: 
Eight drugs belonging to pyridine & mannich bases were selected for systematic screening for 
cytotoxicity as a means of identifying potential anti-tumor drug moieties.  Long-term cytotoxicity 
studies were performed on HEp-2 and Vero cell lines and mouse lung & kidney primary cultures. 
The cytotoxic effect of all the eight drugs was estimated by dye exclusion, protein synthesis 
estimation and MTT assay methods. All studies confirmed that the drug activity was significant 
only at very high concentration. 
 
COMPUTER KNOWLEDGE 
• Windows, Linux, MS Office 
• Working knowledge in  C, HTML, ORACLE       
• Working knowledge of Bioinformatics related software and tools like EMBOSS, GCG, Vector 
NTI, ClustalW, FASTA, BLAST, SCOP, FUGUE, J-Pred, 3DPSSM, PDB-BLAST, Swiss-Model, 
SwissPDB Viewer, PDB tool, RASMOL, Pfam.  
 
PUBLICATIONS 
• Comparative cytotoxic studies of synthetic drugs in established cell lines and primary culture, 
paper accepted for presentation at 52nd IPC held at Hyderabad. 
• Hepatoprotective effect of the alkaloid fraction of Solanum pseudocapsicum leaves, 
Pharmaceutical Biology –2003; 41: 443 - 448  
• The cytotoxic activity of the total alkaloids isolated from different parts of Solanum 
pseudocapsicum,  Biol Pharm Bull. 2004 Apr;27(4):528-30. 
 
 
